From the recent medical literature...
1. A Prospective Evaluation of ED Bedside Ultrasonography for the Detection of Acute Cholecystitis
Summers SM, et al. Ann Emerg Med. 2010;56:114-122.
Study objective
We assess the diagnostic accuracy of emergency physician–performed bedside ultrasonography and radiology ultrasonography for the detection of cholecystitis, as determined by surgical pathology.
Methods
We conducted a prospective, observational study on a convenience sample of emergency department (ED) patients presenting with suspected cholecystitis from May 2006 to February 2008. Bedside gallbladder ultrasonography was performed by emergency medicine residents and attending physicians at an academic institution. Emergency physicians assessed for gallstones, a sonographic Murphy's sign, gallbladder wall thickness, and pericholecystic fluid, and the findings were recorded before formal imaging. The test characteristics of bedside and radiology ultrasonography were determined by comparing their respective results to pathology reports and clinical follow-up at 2 weeks.
Results
Of the 193 patients enrolled, 189 were evaluated by bedside ultrasonography. Forty-three emergency physicians conducted the ultrasonography, and each physician performed a median of 2 tests. After the bedside ultrasonography, 125 patients received additional radiology ultrasonography. Twenty-six patients underwent cholecystectomy, 23 had pathology-confirmed cholecystitis, and 163 were discharged home to follow-up. Twenty-five were excluded (23 lost to follow-up and 2 unavailable pathology). The test characteristics of bedside ultrasonography were sensitivity 87% (95% confidence interval [CI] 66% to 97%), specificity 82% (95% CI 74% to 88%), positive likelihood ratio 4.7 (95% CI 3.2 to 6.9), negative likelihood ratio 0.16 (95% CI 0.06 to 0.46), positive predictive value 44% (95% CI 29% to 59%), and negative predictive value 97% (95% CI 93% to 99%). The test characteristics of radiology ultrasonography were sensitivity 83% (95% CI 61% to 95%), specificity 86% (95% CI 77% to 92%), positive likelihood ratio 5.7 (95% CI 3.3 to 9.8), negative likelihood ratio 0.20 (95% CI 0.08 to 0.50), positive predictive value 59% (95% CI 41% to 76%), and negative predictive value 95% (95% CI 88% to 99%).
Conclusion
The test characteristics of emergency physician–performed bedside ultrasonography for the detection of acute cholecystitis are similar to the test characteristics of radiology ultrasonography. Patients with a negative ED bedside ultrasonography result are unlikely to require cholecystectomy or admission for cholecystitis within 2 weeks of their initial presentation.
Full-text (free): http://www.annemergmed.com/article/S0196-0644(10)00037-5/fulltext
2. Beware of Even a Single Hypotensive Blood Pressure Measurement in Trauma Patients
A single systolic BP reading below 105 mm Hg in the emergency department portends serious injury and the potential need for immediate surgical or endovascular intervention.
Hypotension in trauma patients typically occurs after loss of 30% of total blood and, if persistent, can lead to end-organ injury resulting from hypoperfusion and uncompensated shock. In a prospective observational study at a single level I trauma center, researchers determined the systolic blood pressure (SBP) cutpoint value that best predicts the need for therapeutic surgical or endovascular procedures; 145 adult patients (77% men; 54% with blunt mechanism of injury) who had at least one SBP measurement below 110 mm Hg during initial trauma care were enrolled during a 6-month period. Exclusion criteria were transfer from another hospital, injury more than 2 hours before emergency department (ED) arrival, and isolated prehospital hypotension (below 90 mm Hg) or more than two SBP readings below 90 mm Hg in the ED.
SBP was measured manually within 10 minutes of ED arrival and then automatically at least every 5 minutes for the first 15 minutes, followed by every 15 minutes for the first hour, and then hourly thereafter. Cutpoint analysis showed that a single SBP measurement below 105 mm Hg best predicted need for immediate intervention. Patients with a single SBP measurement below 105 mm Hg, compared to those with no measurement below 105 mm Hg, were significantly more likely to undergo therapeutic intervention (38% vs. 10%), to be admitted to a surgical intensive care unit (54% vs. 25%), and to have a prolonged hospital stay (mean, 8.3 vs. 4.2 days). Other independent predictors of need for therapeutic intervention were gunshot wound mechanism of injury, higher injury severity score, and longer duration of initial resuscitation.
Comment: This small study suggests that even a single SBP measurement below 105 mm Hg in patients with trauma should not be dismissed as erroneous. A single low reading could reflect impending shock and indicate need for aggressive management as well as therapeutic surgical or endovascular procedures.
— John A. Marx, MD, FAAEM. Published in Journal Watch Emergency Medicine July 16, 2010. Citation: Seamon MJ et al. Just one drop: The significance of a single hypotensive blood pressure reading during trauma resuscitations. J Trauma 2010 Jun; 68:1289.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20539171
3. Managing ED Patients with Recent-onset Atrial Fibrillation.
Vinson DR, et al. J Emerg Med. 2010 Jul 13. [Epub ahead of print]
INTRODUCTION
Atrial fibrillation is the most common sustained cardiac rhythm disturbance in adults. As a potent risk factor for ischemic stroke and a cause of worsening heart failure and bothersome symptoms, atrial fibrillation is a major public health problem. The societal and economic burden associated with atrial fibrillation is compounded by its increasing prevalence among our aging population. As a consequence, emergency department (ED) visit rates for symptomatic atrial fibrillation are on the rise and can be expected to increase.
Conventionally, most ED patients with presumed recent-onset atrial fibrillation (≤ 48 hours) have been admitted to the hospital to evaluate for more serious conditions (e.g., myocardial infarction, pulmonary embolism) as well as to monitor for possible acute complications. More recently, there has been a trend in several countries to attempt elective cardioversion without anticoagulation in a sub-population of stable ED patients with presumed recent-onset atrial fibrillation. This more aggressive approach has been associated with a high rate of cardioversion to sinus rhythm and a low rate of hospitalization and complications, factors that support its safety and effectiveness. However, no consensus yet exists about whether an initial aggressive approach is better than conventional ED management, and, if so, in which subset of patients it might best be applied.
We undertook this prospective study of a convenience sample of community ED patients with presumed recent-onset atrial fibrillation or flutter to describe our practice patterns and to determine the rate of adverse events in the ED and the incidence of thromboembolic events within 30 days of index presentation.
ABSTRACT
BACKGROUND: The management of emergency department (ED) patients with presumed recent-onset atrial fibrillation or flutter 48h or less in duration varies widely.
OBJECTIVE AND METHOD: We conducted a prospective study across three affiliated community EDs within a large integrated health care delivery system to describe the management of patients with recent-onset atrial fibrillation or flutter, to determine the safety and effectiveness of ED cardioversion, and to measure the incidence of thromboembolism 30 days after discharge.
RESULTS: We enrolled 206 patients with convenience sampling between June 2005 and November 2007. Mean age was 64.0 ± 14.4 years (range 21-96 years). Patients were grouped for analysis into four categories based on whether cardioversion was 1) spontaneous in the ED (59; 28.6%); 2) attempted with electrical or pharmacological means (115; 56.3%), with success in 110 (95.7%); 3) hoped for during a short stint of home observation (16; 7.8%, 11 of which spontaneously converted to sinus rhythm within 24h); or 4) contraindicated (16; 7.8%). Of the entire group, 183 (88.8%) patients were discharged home. Adverse events requiring ED interventions were reported in 6 (2.9%; 95% confidence interval [CI] 1.1-6.2%) patients, all of whom recovered. Two (1.0%; 95% CI 0.1-3.5%) patients were found to have an embolic event on 30-day follow-up.
CONCLUSIONS: Our approach to ED patients with presumed recent-onset atrial fibrillation or flutter seems to be safe and effective, with a high rate of cardioversion and discharge to home coupled with a low ED adverse event and 30-day thromboembolic event rate.
Full-text pdf is available from me upon request.
4. Occult Pneumonia in Infants with High Fever without Source: A Prospective Multicenter Study
Mintegi S, et al. Pediatr Emerg Care 2010;26:470-474.
Background: The prevalence of pneumonia in infants with high fever without source (FWS; temperature, ≥39.0°C) and a white blood cell (WBC) count greater than 20 × 109/L (occult pneumonia) has been reported to be 20% before the introduction of the 7-valent pneumococcal conjugated vaccine (PCV7). This is the main reason for carrying out chest x-ray (CXR) on infants with high FWS. The aims of this study were to establish the prevalence of occult pneumonia in well-appearing infants with high FWS (temperature, ≥39.0°C) and a WBC count greater than 20 × 109/L in the era of PCV7 and to analyze the value of WBC, absolute neutrophil count (ANC), and C-reactive protein (CRP) level as predictors of the risk of occult pneumonia in these patients.
Patients and Methods: We conducted a multicenter prospective study in 4 pediatric emergency departments including children younger than 36 months with FWS (temperature, ≥39.0°C) and a WBC count higher than 20 × 109/L on whom a CXR was performed in the absence of respiratory findings. Physicians completed a questionnaire when observing the infant, and the attending physician or, when in doubt, the radiologist interpreted the CXR. Multivariable binary logistic regression was used to estimate the adjusted relative influences of the aforementioned factors on the prevalence of radiological pneumonia.
Results: During an entire year (September 2006 to September 2007), we included 188 infants (aged 1-36 months; 56.2% were males) with high FWS and a WBC count greater than 20 × 109/L (range, 20-44.7 × 109/L) on whom a CXR was performed. Of the 188 chest radiographs obtained, 37 (19.7%) were interpreted by the radiologist. Consolidation in the chest radiographs was detected in 25 (13.3%). The probability of an infant with high FWS and WBC of 20 × 109/L or greater having pneumonia was related to 3 of the studied variables: age, ANC, and serum CRP level.
The incidence of pneumonia increased with age (odds ratio [OR] of 2.62 for infants older than12 months; 95% confidence interval [95% CI], 1.04-6.60), CRP level greater than 100 mg/L (OR, 3.18; 95% CI, 1.19-8.51), and ANC greater than 20 × 109/L (OR, 3.52; 95% CI, 1.37-9.06).
White blood cell count was not predictive of occult pneumonia when ANC was taken into account.
Conclusions: In the era of PCV7, the incidence of pneumonia in infants younger than 36 months with high FWS and WBC count greater than 20 × 109/L seems to be lower than that previously reported. However, this is not a uniform group because the incidence of pneumonia increases in infants older than 12 months and with higher ANC and serum CRP level.
5. The Presence of Urinary Nitrites Is a Significant Predictor of Pediatric Urinary Tract Infection Susceptibility to First- and Third-Generation Cephalosporins
Weisz D, et al. J Emerg Med. 2010;39:6-12.
Background: Previous studies in adults have refuted the use of nitrites as a predictor of bacterial resistance to both trimethoprim-sulfamethoxazole and cephalosporins. Some centers now consider first-line outpatient therapy with an oral third-generation cephalosporin appropriate for young children.
Objective: The objective of this study was to determine if nitrite-negative pediatric urinary tract infections (UTIs) were more likely than nitrite-positive UTIs to be resistant to cephalosporins. This may enable physicians to adjust antimicrobial therapy before patients leave the Emergency Department (ED) to avoid the complications of ineffectively treated pediatric UTIs.
Methods: A retrospective chart review examined, over a 9-month period, 173 pediatric patients who were diagnosed with a clinical UTI in the ED and who also had a positive urine culture and a recorded dipstick at the time of visit. The chi-squared test and Fisher's exact test were used to compare nitrite-negative vs. nitrite-positive UTIs for resistance to third-generation cephalosporins and other empiric antimicrobials. Results: For third-generation cephalosporins, 1.4% of nitrite-positive UTIs were resistant, whereas 14.4% of nitrite-negative UTIs were resistant (95% confidence interval [CI] −0.22 to −0.05). For first-generation cephalosporins, 8.4% were resistant in the nitrite-positive group, compared to 22.2% in the nitrite-negative group (95% CI −0.24 to −0.03).
Conclusion: The absence of urinary nitrites is a significant indicator for potential resistance to cephalosporins in pediatric UTIs. Due to low levels of pediatric UTI resistance, cephalosporins continue to represent useful empiric therapy in the general pediatric population. However, in high-risk patients, physicians may opt to alter their empiric choice of antibiotic based on the presence of urinary nitrites.
6. Bystander CPR: (Gladly) Skip the Rescue Breathing
A randomized trial shows no difference in adult patient outcomes with the two approaches.
A previous nonrandomized study showed improved outcomes from adult cardiac arrest with compression-only cardiopulmonary resuscitation (CPR) compared with conventional CPR (JW Emerg Med Mar 30 2007). Now, researchers compared outcomes with the two methods in a randomized study of consecutive 911 calls for cardiac arrest to three emergency medical services systems (2 in Washington State and 1 in London). After determining patient eligibility (unconscious, not breathing normally, bystander CPR not already under way), dispatchers randomly assigned patients to chest compression only or conventional CPR and provided instructions to bystanders about how to perform the assigned method. Patients who were younger than 18 years or who had arrest because of trauma, drowning, or asphyxiation were excluded. During the study period, which ranged from 3 to 5 years at the three sites, 1941 patients were enrolled.
No significant differences were noted between the chest-compression–only and conventional CPR groups in rates of survival to hospital discharge — the primary outcome — (12.5% and 11.0%) or favorable neurological status at discharge (14.4% and 11.5%). Prespecified subgroup analysis of patients with cardiac causes of arrest showed no significant difference in overall survival rate between the chest-compression–only and conventional CPR groups (15.5% and 12.3%) but a significant improvement in the rate of neurologically favorable survival in the chest-compression–only CPR group (18.9% vs. 13.5%).
Comment: The finding that chest compression alone is not inferior to chest compression plus rescue breathing is important, because doing away with breathing might increase the prevalence of bystander CPR. This simpler technique should be adopted for both bystanders and basic-level prehospital providers. The authors note that the finding from the subgroup analysis should prompt research in "targeted application of type-specific CPR."
— J. Stephen Bohan, MD, MS, FACP, FACEP. Published in Journal Watch Emergency Medicine July 28, 2010. Citation: Rea TD et al. CPR with chest compression alone or with rescue breathing. N Engl J Med 2010 Jul 29; 363:423.
Abstract: http://www.nejm.org/doi/full/10.1056/NEJMoa0908993
7. California Department of Public Health Expands Indications for Tdap Immunization
Date: 7/19/2010. Number: 10-048U
To protect Californians against the current epidemic levels of pertussis (whooping cough) health experts at the California Department of Public Health (CDPH) today broadened recommendations for immunizing against pertussis and reiterated the importance of getting vaccinated.
“We are facing what could be the worst year for pertussis that this state has seen in more than 50 years,” said CDPH Chief of the Center for Infectious Disease Dr. Gilberto Chávez, who also is the state’s epidemiologist. “We are urging health providers to broaden their use of the pertussis vaccine and we are urging Californians to take the simple step of getting vaccinated to prevent pertussis.”
In addition to the typical series of childhood pertussis immunizations, CDPH now recommends an adolescent-adult pertussis booster vaccine (Tdap) for:
• anyone 7 years and older who is not fully immunized, including those who are more than 64 years old,
• women of childbearing age, before, during, or immediately after pregnancy, and
• other people who have contact with pregnant women or infants.
“Considering that immunity from pertussis vaccine or disease wears off and that most adults are susceptible to pertussis, now is the time for Californians to get immunized to protect themselves and their families,” said Chávez. “In particular, all family members and caregivers of infants should get the booster vaccine.”
Full-text: http://www.cdph.ca.gov/Pages/PH10-048.aspx
8. Treatment for Acute ACL Tears: Skip the OR?
In young, active adults with an acute anterior cruciate ligament (ACL) injury, rehabilitation plus early ACL reconstruction was not superior to rehabilitation plus optional delayed ACL reconstruction with respect to pain, symptoms, knee function, and knee-related quality of life, and it resulted in significantly more knee reconstructions.
Abstract: http://www.nejm.org/doi/full/10.1056/NEJMoa0907797
9. Traumatic Occult Pneumothorax Can Be Managed Expectantly
By Robert Saunders. NEW YORK (Reuters Health) Jul 21 - Observation of traumatic occult pneumothorax is apparently just as safe as immediate tube thoracostomy, according to a July 10th online report in Resuscitation.
"In an era when comparative effectiveness research is becoming widely recognized as important, it is crucial to evaluate the effectiveness, benefits, and harms of different treatment options, especially those things that we consider 'common practice' but have never properly examined," said lead author Dr. Kabir Yadav of George Washington University in Washington, DC, in e-mail to Reuters Health.
Dr. Yadav and colleagues evaluated the necessity of the common practice of tube thoracostomy for post-injury occult pneumothorax, i.e., pneumothorax that is not seen on the initial chest x-ray but appears on CT scan.
A literature search identified over 400 relevant articles comparing management strategies, of which 3 randomized trials involving a total of 101 patients met quality standards that made them suitable for analysis.
"Our review of the literature showed that hospital observation alone, without a chest tube, could yield the same results as far as patient-oriented outcomes are concerned," Dr. Yadav said.
Specifically, the relative risks of pneumothorax progression, development of pneumonia, development of empyema, and mortality were not significantly different with one approach vs the other.
While they conclude that observation is a safe option in this setting, the researchers acknowledge that several non-clinical factors "might impact the physicians' decision to manage occult pneumothorax." These include the availability of proper follow-up after discharge, and patient preferences after being informed of the pros and cons.
The authors also caution that watchful waiting might not be safe in patients with occult pneumothorax who undergo positive pressure ventilation.
Abstract: http://www.resuscitationjournal.com/article/S0300-9572(10)00261-3/abstract
10. Routine ED HIV Screening in Denver Yields Only Small Increase in Newly Diagnosed Cases
Daniel M. Keller, PhD. Presenting for the Denver Emergency Department HIV Opt-Out Study Group, Jason Haukoos, MD, from the Denver Health Medical Center in Colorado, reported that nontargeted opt-out screening could newly identify HIV infected individuals. Most of them were identified late in the course of their infections and met the criteria for a diagnosis of AIDS. Patients newly diagnosed with nontargeted opt-out testing had a median CD4+ cell count of 69 cells/μL, compared with 13 cells/μL for patients in the diagnostic phase of the study (P = .02). Only 4 patients diagnosed during the opt-out phase had CD4+ cell counts above 350 cells/μL.
HIV infection continues to be a public health problem in the United States, with an estimated 1 million people infected — 230,000 of those undiagnosed — and 56,000 new infections yearly, according to the study authors. In 2006, the Centers for Disease Control and Prevention published guidelines recommending routine (nontargeted) widespread screening for HIV in settings in which the prevalence of undiagnosed infection is 0.1% or greater.
"They also called specifically for the performance of opt-out screening — the idea that patients have to actively opt out of screening or otherwise be tested," Dr. Haukoos said. EDs have been a focus of this effort, despite a lack of evidence that additional infected patients will be identified.
The Denver study was conducted from April 2007 to April 2009 in an urban public-safety-net hospital ED. It used an equivalent time-samples design: 4-month periods of opt-out routine screening alternating with equivalent periods of physician-directed diagnostic testing. In the opt-out periods, patients could decline routine screening. The annual ED census at the hospital is 55,000 patient visits. The study involved patients 16 years and older who could give consent for rapid HIV testing.
During the opt-out phases, 28,043 patients were eligible for screening, 6,702 were screened, and 231 underwent diagnostic testing. Of the 6,702 screened, 10 (0.15%; 95% confidence interval [CI], 0.07% - 0.27%) were newly diagnosed with HIV. Of the 21,281 patients who opted out or were opted out by registration personnel (76% of the eligible population), 231 (1%) subsequently underwent diagnostic testing, and 5 patients (2.2%; 95% CI, 0.7% - 5.0%) tested positive.
In the diagnostic phases of the study, 29,925 patients were eligible, 243 underwent testing, and 4 received a new HIV diagnosis (1.6% of those tested; 95% CI, .5% - 4.2%).
Therefore, the opt-out phase of the study produced an overall prevalence rate (including patients diagnostically tested) of 15 of 28,043 (0.05%; 95% CI, 0.03% - 0.09%), compared with an overall prevalence in the diagnostic phase of 4 of 29,925 (0.01%; 95% CI, 0.004% - 0.03%). Nontargeted opt-out screening for HIV was significantly independently associated with new HIV diagnoses, with a risk ratio of 3.6 (95% CI, 1.2 - 10.8) after adjustment for patient demographics, insurance status, and whether diagnostic testing was performed in the opt-out phase.
Another component of the study looked at whether rapid opt-out testing affected the workflow in the ED. The differences between the 2 phases of the study in terms of waiting time, length of stay in the ED for those admitted or not admitted, and boarding time were statistically significant (P less than .001 for all), but were still very small — in the order of 12 minute differences (favoring one phase or the other, depending on the specific parameter). "There is really no substantive impact of performing nontargeted opt-out screening on emergency department operational processes," Dr. Haukoos concluded.
The authors note that a limitation of the study is the fact that patients could not be randomized because the screening was fully integrated into ED care and occurred 24 hours a day in a high-volume ED setting. In addition, the study was performed at a single institution and might not be representative of other institutions or settings.
In summary, nontargeted opt-out rapid HIV screening was associated with the identification of more patients with newly diagnosed HIV infection than diagnostic testing. The number of patients identified was modest, and a substantial proportion was identified relatively late in the course of the disease.
JAMA. 2010;304:284-292, 348-349. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20639562
11. Cricoid Pressure During Intubation of Trauma Patients: Helpful or Harmful?
Release of cricoid pressure improved the laryngoscopic view in 11 of 22 patients.
The purported value of cricoid pressure during intubation is to protect the pulmonary tree from aspiration of vomitus. However, recent evidence suggests that cricoid pressure impairs laryngoscopic view, reduces bag-valve-mask ventilation efficiency, and does not prevent aspiration (Ann Emerg Med 2007; 50:653).
In a prospective observational study, researchers compared the effect on laryngoscopic view of three laryngeal maneuvers (release of cricoid pressure, BURP [backwards, upwards, rightward pressure], and laryngeal manipulation under direct vision) in 400 adult trauma patients who were intubated with cricoid pressure in a London air–ground emergency medical services system during a 16-month period. Airways were managed by attending or senior residents in emergency medicine, critical care, or anesthesia. Removal of the laryngoscope, additional preoxygenation, and repeat laryngoscopy was defined as an additional attempt.
Overall, 87.5% of patients were intubated on the first attempt, and 98.8% were intubated within two attempts. Four patients required three attempts, and one patient required rescue cricothyroidotomy. The laryngoscopic view was improved by at least one Cormack-Lehane grade with release of cricoid pressure in 11 of 22 patients (50%), with laryngeal manipulation in 15 of 25 patients (60%), and with the BURP maneuver in 9 of 14 patients (64%). No maneuver made the view worse. Release of cricoid pressure was followed by vomiting in two patients (9%), both of whom had prolonged bag-valve-mask ventilation; neither patient developed aspiration pneumonia.
Comment: Cricoid pressure during intubation is considered necessary by many emergency medicine societies. These findings place this recommendation under scrutiny, just as the widely promulgated need for in-line cervical stabilization has recently been challenged (JW Emerg Med Aug 14 2009). Until a randomized, prospective trial demonstrates benefit from cricoid pressure, practitioners performing emergency trauma (and nontrauma) intubations should consider cricoid pressure an optional maneuver and be aware that it might lower the chance for successful intubation.
— John A. Marx, MD, FAAEM. Published in Journal Watch Emergency Medicine July 23, 2010.
Citation: Harris T et al. Resuscitation 2010 Jul; 81:810.
Abstract: http://www.resuscitationjournal.com/article/S0300-9572(10)00130-9/abstract
12. Bougie-Assisted Cricothyrotomy: Simple and Effective
For novice operators, the bougie-assisted technique was faster and easier than the standard surgical technique.
Hill C, et al. Acad Emerg Med. 2010;17:666-669.
Objectives: The objective was to compare time to completion, failure rate, and subjective difficulty of a new cricothyrotomy technique to the standard technique. The new bougie-assisted cricothyrotomy technique (BACT) is similar to the rapid four-step technique (RFST), but a bougie and endotracheal tube are inserted rather than a Shiley tracheostomy tube.
Methods: This was a randomized controlled trail conducted on domestic sheep. During a 3-month period inexperienced residents or students were randomized to perform cricothyrotomy on anesthetized sheep using either the standard technique or the BACT. Operators were trained with an educational video before the procedure. Time to successful cricothyrotomy was recorded. The resident or student was then asked to rate the difficulty of the procedure on a five-point scale from 1 (very easy) to 5 (very difficult).
Results: Twenty-one residents and students were included in the study: 11 in the standard group and 10 in the BACT group. Compared to the standard technique, the BACT was significantly faster with a median time of 67 seconds (interquartile range [IQR] = 55–82) versus 149 seconds (IQR = 111–201) for the standard technique (p = 0.002). The BACT was also rated easier to perform (median = 2, IQR = 1–3) than the standard technique (median = 3, IQR = 2–4; p = 0.04). The failure rate was 1/10 for the BACT compared to 3/11 for the standard method (p = NS).
Conclusions: This study demonstrates that the BACT is faster than the standard technique and has a similar failure rate when performed by inexperienced providers on anesthetized sheep.
13. Images in Emergency Medicine
Radiologic Signs of Pneumoperitoneum
http://www.nejm.org/doi/full/10.1056/NEJMicm0904627
Beware Inadvertent PTX from NG Tube
http://www.nejm.org/doi/full/10.1056/NEJMicm0912444
A Woman with Ankle Pain
http://www.annemergmed.com/article/S0196-0644(09)01506-6/fulltext
Woman with Unresponsiveness
http://www.annemergmed.com/article/S0196-0644(09)01545-5/fulltext
14. Walking the Tightrope of Health Insurance Reform between 2010 and 2014
Christopher C. Jennings, and Katherine J. Hayes, J.D. New Engl J Med 2010
Both political parties wax poetic about the need for popular insurance reforms, but legislating what is necessary and implementing it properly has always been the trick. In the aftermath of the enactment of the Affordable Care Act, President Barack Obama and his administration are walking a policy tightrope: they must implement meaningful reforms in the transition to a stable insurance market without unduly disrupting existing insurance arrangements by means of excessive increases in premiums or declines in coverage.
Philosophically, the political extremes could not differ more in their views of the correct approach. Americans on the far left believe in aggressive regulation of private insurance to guarantee access and limit profit. In their view, if regulation drove insurers with high profits or skimpy benefits out of the marketplace, consumers would be better served — even if it meant fewer plan choices and some disruption early in the process. Those on the far right believe that regulation of private insurance should be limited and consumers should face financial incentives and penalties to encourage healthy lifestyle choices and cost-effective health care decisions. In their view, if less regulation promotes innovation and choice at the cost of some discrimination, so be it.
Neither of these camps will be satisfied with the implementation of the insurance reforms. Many reform opponents seem to be eagerly awaiting implementation decisions justifying their claim that the president broke his promise to permit Americans to keep their current coverage. Never mind that before reform passed, many small-business employers had changed or dropped their employee coverage, causing considerable disruption. Conversely, many reform supporters will accuse the administration of being too timid because of an overly close relationship with insurers. Never mind that excessively disruptive early implementation would threaten the ultimate goal of coverage for all Americans.
Implementing insurance reform is challenging from a policy and a political perspective, particularly given the fragmentation of U.S. insurance markets. Which rules apply to a particular plan will depend on whether it’s an individual or a group plan, whether a group plan is large or small and insured or self-funded, and whether it existed when the law was enacted…
The remainder of the essay (free): http://healthcarereform.nejm.org/?p=3768
15. Diagnosing Gout by the Non-Specialist: Which Clinical Variables are Most Useful?
Janssens HJ, et al. Arch Intern Med. 2010 Jul 12;170(13):1120-6.
BACKGROUND: Most cases of acute gouty arthritis are diagnosed in primary care and without joint fluid analysis in many instances. Our objectives were to estimate the validity of this diagnosis by family physicians and to develop a diagnostic rule.
METHODS: Patients with monoarthritis recruited in an open Dutch population with gout by family physician diagnosis were enrolled in a diagnostic study (March 24, 2004, through July 14, 2007). Validity variables were estimated using 2 x 2 tables, with the presence of synovial monosodium urate crystals as the reference test. For development of the diagnostic rule, clinical variables (including the presence of synovial monosodium urate crystals) were collected within 24 hours. Statistically significant variables and predefined variables were separately entered in multivariate logistic regression models to predict the presence of synovial monosodium urate crystals. Diagnostic performance of the models was tested by receiver operating characteristic curve analysis. The most appropriate model was transformed to a clinically useful diagnostic rule.
RESULTS: Three hundred twenty-eight patients were included in the study. The positive and negative predictive values of family physician diagnosis of gout were 0.64 and 0.87, respectively. The most appropriate model contained the following predefined variables: male sex, previous patient-reported arthritis attack, onset within 1 day, joint redness, first metatarsophalangeal joint (MTP1) involvement, hypertension or 1 or more cardiovascular diseases, and serum uric acid level exceeding 5.88 mg/dL (to convert serum uric acid level to micromoles per liter, multiply by 59.485). The area under the receiver operating characteristic curve for this model was 0.85 (95% confidence interval, 0.81-0.90). Performance did not change after transforming the regression coefficients to easy-to-use scores and was almost equal to that of the statistically optimal model (area under the receiver operating characteristic curve, 0.87; 95% confidence interval, 0.83-0.91).
CONCLUSIONS: The validity of family physician diagnosis of acute gouty arthritis was moderate in this study. An easy-to-use diagnostic rule without joint fluid analysis was developed for their use.
The Diagnostic Rule: On the diagnostic rule, a score of 4 or less ruled out gout in almost 100% of patients. Diagnoses such as rheumatoid arthritis, pseudogout, psoriatic arthritis, and reactive arthritis must be considered in these patients. Among patients with a score of 8 or higher, gout was confirmed in more than 80%, indicating gout-specific management options such as systemic corticosteroid use (instead of nonsteroidal anti-inflammatory drugs), uric acid–lowering therapy if indicated, and evaluation of gout-associated cardiovascular and renal diseases.
More on gout: http://cmeaccess.com/cme/ajm_gout_program/index.asp
16. Canadian Association of Emergency Physicians position statement on cellphone use while driving
Huang D, et al. CJEM 2010;12(4):365-370
Summary
Distracted driving caused by cellphone use is a significant source of needless injuries. These injuries place unnecessary financial burden, emotional stress and health care resource misuse on society. This paper states the Canadian Association of Emergency Physician’s (CAEP’s) position on cellphone use while driving.
In recent years, numerous studies were conducted on the danger of cellphone use while driving. Research has shown that cellphone use while driving negatively impacts cognitive functions, visual fields, reaction time and overall driving performances. Some studies found that cellphone use is as dangerous as driving under the influence of alcohol. Moreover, vehicle crash rates were shown to be significantly higher when drivers used cellphones.
Countermeasures have been implemented in recent years. Over 50 countries worldwide have laws limiting the use of cellphones while driving. Six Canadian provinces, Newfoundland and Labrador, Nova Scotia, Quebec, Ontario, British Columbia and Saskatchewan, currently have legislation prohibiting cellphone use. Other provinces are considering implementing similar bans.
As emergency physicians, we must advocate for injury prevention. Cell phone related road traumas are avoidable. CAEP supports all measures to ban cellphone use while driving.
The Canadian Association of Emergency Physicians recommends the following measures:
1. CAEP advocates for a total ban on hand-held and handsfree cellphone use while driving.
2. CAEP supports public awareness campaigns to inform people about the dangers of using cellphones and other hands-free electronic devices while driving.
3. CAEP supports discussions and seminars on the dangers of cellphone use while driving at future national conferences to raise awareness within the medical community.
4. CAEP supports continuing research into the danger of distracted driving.
5. CAEP supports legislations and policies banning all use of cellphones while driving.
Remainder of the evidence-based position statement (free):
In English http://www.cjem-online.ca/v12/n4/p365
In French http://www.cjem-online.ca/v12/n4/p371
17. End-Tidal CO2 Not Sufficiently Concordant with ABG CO2 in Dyspneic ED Patients (Too Bad!)
Delerme S, et al. Amer J Emerg Med. 2010;28:711-714.
Background
End-tidal carbon dioxide pressure (etCO2) is widely used in anaesthesia and critical care in intubated patients. The aim of our preliminary study was to evaluate the feasibility of a simple device to predict capnia in spontaneously breathing patients in an emergency department (ED).
Patients and methods
This study was a prospective, nonblind study performed in our teaching hospital ED. We included nonintubated patients with dyspnea (≥18 years) requiring measurement of arterial blood gases, as ordered by the emergency physician in charge. There were no exclusion criteria. End-tidal CO2 was measured by an easy-to-use device connected to a microstream capnometer, which gave a continuous measurement and graphical display of the etCO2 level of a patient's exhaled breath.
Results
A total of 43 patients (48 measurements) were included, and the majority had pneumonia (n = 12), acute cardiac failure (n = 8), asthma (n = 7), or chronic obstructive pulmonary disease exacerbation (n = 6). Using simple linear regression, the correlation between etCO2 and Paco2 was good (R = 0.82). However, 18 measurements (38%) had a difference between etCO2 and Paco2 of 10 mm Hg or more. The mean difference between the Paco2 and etCO2 levels was 8 mm Hg. Using the Bland and Altman matrix, the limits of agreement were −10 to +26 mm Hg.
Conclusion
In our preliminary study, etCO2 using a microstream method does not seem to accurately predict Paco2 in patients presenting to an ED for acute dyspnea.
18. Attrition from EM Clinical Practice is Low in the United States
Ginde AA, et al. Ann Emerg Med. 2010;56:166-171.
Study objective: We estimate the annual attrition from emergency medicine clinical practice.
Methods: We performed a cross-sectional analysis of the American Medical Association's 2008 Physician Masterfile, which includes data on all physicians who have ever obtained a medical license in at least 1 US state. We restricted the analysis to physicians who completed emergency medicine residency training or who obtained emergency medicine board certification. We defined attrition as not being active in emergency medicine clinical practice. Attrition was reported as cumulative and annualized rates, with stratification by years since training graduation. Death rates were estimated from life tables for the US population.
Results: Of the 30,864 emergency medicine–trained or emergency medicine board-certified physicians, 26,826 (87%) remain active in emergency medicine clinical practice. Overall, type of attrition was 45% to non–emergency medicine clinical practice, 22% retired, 14% administration, and 10% research/teaching. Immediate attrition (within 2 years since training graduation) was 6.5%. The cumulative attrition rates from 2 to 15 years postgraduation were stable (5% to 9%) and thereafter were progressively higher, with 18% having left emergency medicine clinical practice at 20 years postgraduation and 25% at 30 years postgraduation. Annualized attrition rates were highest for the first 5 years postgraduation and after 40 years postgraduation; between 5 and 40 years, the rates remained low (less than 1%). The overall annual attrition rate from emergency medicine clinical practice, including estimated death rate, was approximately 1.7%.
Conclusion: Despite the high stress and demands of emergency medicine, overall attrition remains low and compares favorably with that of other medical specialties. These data have positive implications for the emergency physician workforce and are important for accurate estimation of and planning for emergency physician workforce needs.
19. A survey of ED use in patients with cyclic vomiting syndrome
Venkatesan T, et al. BMC Emergency Medicine 2010, 10:4
Introduction
Cyclic vomiting syndrome (CVS) is a chronic idiopathic functional gastrointestinal disorder that is characterized by recurrent, stereotypical, disabling, discrete episodes of intense nausea and vomiting that last a few hours to days, interspersed with varying symptom-free intervals. This disorder is primarily recognized in children, with increasing recognition in adults. The pathophysiology of CVS is unknown, but several theories have been advanced including a dysfunctional brain-gut interaction involving corticotrophin-releasing factor [1], dysregulation of the autonomic nervous system and mitochondrial dysfunction [2-9].
The diagnosis of CVS in adults is based on Rome III criteria: 1) Stereotypical episodes of vomiting regarding onset (acute) and duration (less than 1 week); 2) Three or more discrete episodes in the prior year; and 3)Absence of nausea and vomiting between episodes and absence of metabolic, gastrointestinal, central nervous system structural or biochemical disorders. A personal or family history of migraines is supportive of the diagnosis [10]. The differential diagnosis of CVS includes various gastrointestinal, endocrine, neurological and metabolic problems that can mimic CVS, e.g., hydronephrosis and intestinal malrotation [11-13]. Unfortunately CVS episodes are typically misdiagnosed and there is a 3-8 year delay in diagnosis in adults [14,15] and 2.5 year delay in children [16]. Given the problems with diagnosis of this disorder, it is likely that CVS is more common than currently thought.
In addition, diagnostic uncertainty may lead to suboptimal acute care. Patients with CVS frequently seek care in, or are referred to, the emergency department (ED) for management of acute episodes of vomiting associated with dehydration and electrolyte disturbances. Anecdotally, we believe that familiarity with this disorder among ED personnel is low. The impact of this on acute management and the quality of the patient experience is unclear.
Abstract
Background: Cyclic vomiting syndrome (CVS), a chronic disorder characterized by recurrent episodes of vomiting, is frequently unrecognized and is associated with high utilization of emergency department (ED) services.
Methods: A web-based survey was posted on the Cyclic Vomiting Syndrome Association (CVSA) website to assess utilization of ED services in patients with CVS.
Results: Of 251 respondents, 104 (41.4%) were adult CVS patients and 147 (58.6%) were caregivers of pediatric and adult patients. In the adult group, the median number of ED visits for CVS symptoms was 15(range 1 - 200), with a median of 7 ED visits prior to a diagnosis of CVS (range 0 - 150). In the caregiver group, the median number of ED visits was 10 (range 1 - 175) and the median number of ED visits prior to a diagnosis of CVS was 5 (range 0 - 65). CVS was not diagnosed in the ED in 89/104 (93%) adults and 119/147 (93%) patients in the caregiver group. CVS was not recognized in the ED in 84/95 (88%) of adults and 97/122 (80%) of patients in the caregiver group, despite an established diagnosis of CVS.
Conclusion: There is a sub-group of adult and pediatric CVS patients who are high utilizers of ED services and CVS is not recognized in the ED in the majority of patients. Improved efforts to educate ED physicians are indicated to optimize treatment of patients with CVS and to decrease potential overuse of ED services.
Full-text (free): http://www.biomedcentral.com/1471-227X/10/4
20. Evaluating the Sensitivity of Visual Xanthochromia in Patients with Subarachnoid Hemorrhage
Arora S, et al. J Emerg Med. 2010;39:13-16.
Combined computed tomography and cerebrospinal fluid (CSF) analysis has been shown to be 100% sensitive for detecting subarachnoid hemorrhage (SAH) when CSF is obtained between 12 h and 2 weeks from time of headache onset and spectrophotometry is used to evaluate CSF for xanthochromia. Because most hospitals do not use spectrophotometry, we sought to evaluate the sensitivity of CSF analysis for xanthochromia by visual inspection.
We retrospectively identified all patients seen in the Emergency Department (ED) with an ED discharge diagnosis of SAH from June 1993 to November 2005. A structured chart review was performed on all patients with the additional billed procedure charge for “lumbar puncture” or “spinal tap.” Data collected included: CSF color, time from headache onset to CSF collection, and confirmation of SAH by advanced imaging.
There were 1323 patients diagnosed with SAH, and 102 of these also had CSF collected. Of these, 81 charts were available for review. By predetermined protocol, 35 were excluded for lack of a report of CSF color, 1 was excluded because the time from headache onset to CSF collection was less than 12 h, and 26 were excluded for lack of documentation of a definitive imaging study. Of the remaining 19, 9 were found to have xanthochromic CSF and 10 were found to have colorless CSF, resulting in a sensitivity for visual inspection of CSF of 47.3% (95% confidence interval 24.4–71.1%).
Visual inspection of CSF supernatant for xanthochromia lacks the sensitivity necessary to reliably exclude the diagnosis of SAH.
21. Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study
Runeson B, et al. BMJ 2010;341:c3222
Objective: To study the association between method of attempted suicide and risk of subsequent successful suicide.
Design: Cohort study with follow-up for 21-31 years.
Setting: Swedish national register linkage study.
Participants: 48 649 individuals admitted to hospital in 1973-82 after attempted suicide.
Main outcome measure: Completed suicide, 1973-2003. Multiple Cox regression modelling was conducted for each method at the index (first) attempt, with poisoning as the reference category. Relative risks were expressed as hazard ratios with 95% confidence intervals.
Results: 5740 individuals (12%) committed suicide during follow-up. The risk of successful suicide varied substantially according to the method used at the index attempt. Individuals who had attempted suicide by hanging, strangulation, or suffocation had the worst prognosis. In this group, 258 (54%) men and 125 (57%) women later successfully committed suicide (hazard ratio 6.2, 95% confidence interval 5.5 to 6.9, after adjustment for age, sex, education, immigrant status, and co-occurring psychiatric morbidity), and 333 (87%) did so with a year after the index attempt. For other methods (gassing, jumping from a height, using a firearm or explosive, or drowning), risks were significantly lower than for hanging but still raised at 1.8 to 4.0. Cutting, other methods, and late effect of suicide attempt or other self inflicted harm conferred risks at levels similar to that for the reference category of poisoning (used by 84%). Most of those who successfully committed suicide used the same method as they did at the index attempt—for example, above 90% for hanging in men and women.
Conclusion: The method used at an unsuccessful suicide attempt predicts later completed suicide, after adjustment for sociodemographic confounding and psychiatric disorder. Intensified aftercare is warranted after suicide attempts involving hanging, drowning, firearms or explosives, jumping from a height, or gassing.
Full-text (free): http://www.bmj.com/cgi/content/full/341/jul13_1/c3222
Thursday, July 29, 2010
Sunday, July 18, 2010
Lit Bits: July 18, 2010
From the recent medical literature...
1. Typical Angina vs. Atypical Chest Pain
In patients presenting to an emergency department, presence and type of symptoms did not predict inducible myocardial ischemia.
Hermann LK, et al. Am J Cardiol. 2010;105:1561-4.
The present study was designed to assess the value of the presenting symptom of "typical" anginal pain, "atypical/nonanginal" pain, or the lack of chest pain in predicting the presence of inducible myocardial ischemia using cardiac stress testing in emergency department patients being evaluated for possible acute coronary syndrome.
We performed a retrospective observational study of adult patients who were evaluated for acute coronary syndrome in an emergency department chest pain unit. The presenting symptoms were obtained from a structured questionnaire administered before stress testing. Patient chest pain was categorized according to the presence of substernal chest pain or discomfort that was provoked by exertion or emotional stress and was relieved by rest and/or nitroglycerin. Chest pain was classified as "typical" angina if all 3 descriptors were present and "atypical" or "nonanginal" if less than 3 descriptors were present. All patients underwent serial biomarker and cardiac stress testing before discharge.
A total of 2,525 patients met the eligibility criteria. Inducible ischemia on stress testing was found in 33 (14%, 95% confidence interval 10% to 19%) of the 231 patients who had typical anginal pain, 238 (11%, 95% confidence interval 10% to 13%) of the 2,140 patients presenting with atypical/nonanginal chest pain, and 25 (16%, 95% confidence interval 11% to 22%) of the 153 patients who had no complaint of chest pain on presentation. Compared to patients with atypical or no chest pain, patients with typical chest pain were not significantly more likely to have inducible ischemia on stress testing (likelihood ratio +1.25, 95% confidence interval 0.89 to 1.78).
In conclusion, in our study, the patients who presented with "typical" angina were no more likely to have inducible myocardial ischemia on stress testing than patients with other presenting symptoms.
2. Dramatic Increase in ED Visits Resulting From Prescription Opioid Use
Deborah Brauser. June 29, 2010 — The estimated number of emergency department (ED) visits involving nonmedical use of prescription opioids increased by 111% during a 5-year period, according to a new study by researchers from the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
Oxycodone, hydrocodone, and methadone products were the opioid pain relievers most frequently involved in these visits, with increases of 152%, 123%, and 73%, respectively.
"These alarming findings provide 1 more example of how the misuse of prescription pain relievers is impacting lives and our health care system," said Pamela S. Hyde, JD, administrator of SAMSHA, Rockville, Maryland, in a statement. "This public health threat requires an all-out effort to raise awareness of the public about proper use, storage, and disposal of these powerful drugs."
"We urgently need to take action," echoed Thomas R. Frieden, MD, MPH, director of the CDC in Atlanta, Georgia, in the same statement. "ED visits involving non-medical use of these prescription drugs are now as common as ED visits for use of illicit drugs. These prescription medicines help many people, but we need to be sure they are used properly and safely."
The findings were reported jointly in a SAMHSA survey report and in the CDC's Morbidity and Mortality Weekly Report, published online June 17.
Important Public Health Issue
"This is something we've been tracking for a number of years, and it's been pretty clear that prescription drug use has been growing over time," Peter Delany, PhD, director of the Office of Applied Studies at SAMSHA, told Medscape Psychiatry. "This [study] was an opportunity for us to work with our partners at CDC to look at 5 years worth of data and to track trends.
"It was a real collaboration with our colleagues at CDC and we were very happy to do it as a joint project, especially because this is a critically important public health issue," added Dr. Delany.
The investigative team evaluated a "stratified, simple random sample" from 220 hospitals with 24-hour EDs between the years 2004 and 2008 from SAMHSA's Drug Abuse Warning Network ED system.
Nonmedical use of a prescription drug was defined as "taking a higher-than-recommended dose, taking a drug prescribed for another person, drug-facilitated assault, or documented misuse or abuse," according to the study authors.
Dramatic Increases
Results showed that the nonmedical use of prescription opioids rose significantly from 144,600 ED visits in 2004 to 305,900 visits in 2008 (P less than .001). It also increased by 29% just between the years 2007 and 2008.
In addition, ED visits during the 5-year period involving nonmedical oxycodone use rose significantly from 41,700 to 105,214 visits a year (P less than .001). Hydrocodone involvement rose from 39,844 to 89,051 visits, and methadone product involvement rose from 36,806 to 63,629 visits.
These increases "reflect, in part, substantial increases in the prescribing of these classes of drugs," the investigators write.
When researchers also looked at the estimated number of nonmedical benzodiazepine-related ED visits, they found an overall increase by 89% between 2004 and 2008 (from 143,500 to 271,700 visits; P = .01).
Individual benzodiazepines also showed significant rises in ED visits during the study period, including a 125% increase for alprazolam (P = .01), 107% increase for lorazepam (P = .006), 72% increase for clonazepam (P less than .001), and 70% increase for diazepam (P = .02). Benzodiazepines were involved in 26% of all opioid-related visits.
Age-specific rates of ED visits in 2008 showed a sharp increase for both opioids and benzodiazepines "after age 17 years, [peaking] in the 21 to 24 years age group, and [declining] after age 54 years," report the study authors. "The largest increases during 2004 to 2008 occurred among persons aged 21 to 29."
Although women had more benzodiazepine-related ED visits than men in 2008 (152,100 vs 119,600, respectively), the difference was not statistically significant.
"These findings indicate substantial, increasing morbidity associated with the nonmedical use of prescription drugs...despite recent efforts to control the problem," write the study authors. "Stronger measures to reduce the diversion of prescription drugs to nonmedical purposes are warranted."
Opportunity for Prevention and Education
"I think the number 1 takeaway is that this is an opportunity for [clinicians] to really think about these findings and then talk about them with their patients," said Dr. Delany. "It's also an opportunity for prevention and education. How do you store and dispose of medications when you don't need them anymore? These answers need to be given not just by the clinician who is prescribing medications but also by pharmacists and other health providers. Also, adults need to be aware of what's going on in their medicine cabinets, especially if there are [young people] in the household."
"The abuse of prescription drugs is our nation's fastest-growing drug problem. And this new study shows it is a problem that affects men and women, people under 21, and those over 21," said R. Gil Kerlikowske, director of the Office of National Drug Control Policy in Rockville, Maryland, in a statement.
"The newly released National Drug Control Strategy contains specific steps that all of us can take to address this issue," added Director Kerlikowske.
Dr. Delany noted that SAMHSA and the CDC plan on participating in more joint research partnerships. "There's a real commitment between my administrator and Dr. Frieden at CDC to keep building on the collaborations that we have done over the years.
"We're a behavioral health statistical unit while their researchers really look at health areas. So the ability to bring behavioral health and health together for these types of mainstream health issues is important, especially because they're both so intertwined," said Dr. Delany.
The study authors and commentators have disclosed no relevant financial relationships.
SAMHSA. "The DAWN Report — Trends in Emergency Department Visits Involving Nonmedical Use of Narcotic Pain Relievers." Released June 18, 2010. http://www.oas.samhsa.gov/2k10/DAWN016/OpioidED.htm
Morb Mortal Wkly Rep. "ED Visits Involving Nonmedical Use of Selected Prescription Drugs." Published online June 17, 2010. http://www.cdc.gov/mmwr/pdf/wk/mm5923.pdf
3. The Impact of Delays to Admission from the ED on Inpatient Outcomes
Huang Q, et al. BMC Emerg Med 2010, 10:16doi:10.1186/1471-227X-10-16
Background
We sought to determine the impact of delays to admission from the Emergency Department (ED) on inpatient length of stay (LOS), and IP cost.
Methods
We conducted a retrospective analysis of 13,460 adult (18 yrs and up) ED visits between April 1 2006 and March 30 2007 at a tertiary care teaching hospital with two ED sites in which the mode of disposition was admission to ICU, surgery or inpatient wards. We defined ED Admission Delay as ED time to decision to admit greater than 12 hours. The primary outcomes were IP LOS, and total IP cost.
Results
Approximately 11.6% (n=1558) of admitted patients experienced admission delay. In multivariate analysis we found that admission delay was associated with 12.4% longer IP LOS (95 % CI 6.6% - 18.5%) and 11.0% greater total IP cost (6.0% - 16.4%). We estimated the cumulative impact of delay on all delayed patients as an additional 2,183 inpatient days and an increase in IP cost of $2,109,173 at the study institution.
Conclusions
Delays to admission from the ED are associated with increased IP LOS and IP cost. Improving patient flow through the ED may reduce hospital costs and improve quality of care. There may be a business case for investments to reduce emergency department admission delays.
Full-text (free): http://www.biomedcentral.com/content/pdf/1471-227x-10-16.pdf
4. Is Computed Tomography Safe?
Rebecca Smith-Bindman, M.D. N Engl J Med. 2010;published online (10.1056/NEJMp1002530)
Ms. C., a 59-year-old schoolteacher, awoke on September 8, 2009, with facial paralysis. In a local emergency room [sic], she underwent computed tomographic (CT) and magnetic resonance imaging (MRI) brain scanning. The scans were normal, Bell's palsy was diagnosed, and the symptoms resolved over the next few weeks. Two weeks later, Ms. C. began losing her hair in a band-like distribution, and the following week she awoke with vertigo and confusion and returned to the emergency room, where repeat CT and MRI scans were normal. Fatigue, malaise, memory loss, and confusion began soon thereafter and have continued, making it difficult for her to work. Review of the first CT scan revealed that she had received a radiation dose to her brain of 6 Gy — approximately 100 times the dose from the average brain CT scan, 10 times the dose from the average brain-perfusion scan, and 3 times the daily dose of radiation treatment for brain cancer. Ms. C. is now a plaintiff in both a federal class-action lawsuit against a CT-scanner manufacturer and a state medical malpractice lawsuit. More than 378 patients in the United States have been identified as having received brain-perfusion scans with similar radiation overdoses, and the Food and Drug Administration (FDA) has issued a national advisory that hospitals should carefully check their CT protocols.
Radiation doses from CT scans are 100 to 500 times those from conventional radiography, depending on what part of the body is imaged. CT-machine manufacturers compete, in part, on the basis of image quality, which is directly associated with radiation dose (see figure). Technical advances such as increased imaging speed have led to new CT scanning techniques that have also boosted doses. For example, the brain-perfusion scan undergone by Ms. C. uses sophisticated techniques for assessing regional blood flow and, even when done correctly, delivers a dose 10 times that of a routine brain CT. Although such imaging techniques may have a role in diagnosis, there are few evidence-based guidelines regarding their appropriate use, and institutional use varies widely, reflecting physicians' preferences and manufacturers' promotion of these capabilities, rather than scientific evidence of improved clinical outcomes. Ms. C. not only received an accidental radiation overdose but also underwent a high-dose brain-perfusion CT when a much-lower-dose, routine head CT would have sufficed.
The rest of the article: Full-text (free): http://content.nejm.org/cgi/content/full/NEJMp1002530
5. Families Don't Trust Bad News from ICU Doctors
By Amy Norton. NEW YORK (Reuters Health) Jul 01 - Families of critically ill patients may often take a more optimistic view of their loved one's condition than doctors do, even when they are given a specific estimate of the chances of survival, a new study suggests.
A number of studies have found that doctors and family members frequently have different opinions on critically ill patients' odds of survival. This raises the question of whether doctors are effectively communicating their estimates of patients' prognosis.
Many experts now recommend that doctors try to give specific numeric estimates of a patient's chances of survival -- rather than "qualitative" information, such as telling families is it "very unlikely" that their loved one will survive.
So for the new study, researchers looked at whether the numeric and qualitative approaches differed in their effects on families' views.
The researchers had 169 family members of patients treated in one intensive care unit view videos that portrayed a doctor discussing a critically ill patient's prognosis with the family.
Half the family members viewed a hypothetical scenario in which the doctor told the family that their relative was "very unlikely" to survive and "very likely" to die. The doctor also said that if he did live, he would probably have to remain on a ventilator. The other half of the family members saw a video with the same scenario, with the exception that the doctor said the patient had a 10% chance of surviving and a 90% chance of dying.
In both cases, the researchers found, study participants came away with a more positive estimate of the hypothetical patient's prognosis than the doctor on the video had given.
They restated the doctor's estimates fairly accurately, but when asked for their own sense of the patient's chances of survival, study participants gave an average estimate of 26% after watching the video where the doctor had said survival was "very unlikely."
Even after viewing the video in which the doctor gave 10% survival odds, study participants still said the patient had, on average, a 22% chance of making it.
"The key finding is that many families don't take physicians' estimates at face value," said Dr. Douglas B. White, of the University of Pittsburgh Medical Center in Pennsylvania, who directed the study.
The findings, reported online June 10th in the American Journal of Respiratory and Critical Care Medicine, also suggest that effective communication with families is not just a matter of giving numeric estimates of the chances of survival, rather than qualitative ones.
This may mean, Dr. White said in an interview, that ICU doctors need to limit the amount of the information they convey, so that family members are less likely to be overwhelmed at a time when they are distraught. They could also try explicitly asking family members if they understood the information they were just given, he said.
Trust is another key issue, the researcher noted. ICU physicians are not the patient's or family's regular doctor, which means family members are being asked to trust the judgment of a stranger.
In this study, participants who reported relatively less trust in doctors also disagreed to a greater extent with the doctor's prognosis estimate in the video.
Dr. White said that it remains unclear exactly how ICU doctors can best establish a level of trust between themselves and family members in such a short and emotionally charged time frame.
Research also suggests that families take a number of factors into consideration, other than the doctor's judgment, when it comes to their own views of a loved one's chances of survival.
In an earlier study, Dr. White and his colleagues found that families of critically ill ICU patients only rarely relied on doctors' prognostication alone.
Instead, they often considered their perceptions of their loved one's strength and "will to live," his or her history of overcoming illness, and their own trust in optimism, intuition and faith.
As for how well doctors are able to estimate prognosis, research suggests they are "fairly accurate" when estimating the general odds of patients in a given situation surviving to hospital discharge, according to Dr. White. They are not as good, however, at predicting whether any one patient will live or die.
There is, Dr. White said, an "inherent uncertainty in medicine," and doctors need to convey that fact to family members as well.
http://ajrccm.atsjournals.org/cgi/content/abstract/201002-0262OCv1
Am J Respir Crit Care Med 2010.
6. Similar Results from Three Immobilization Techniques after Colles Fracture Reduction
Outcomes were similar at 8 weeks and at 6 months with circumferential casting, volar-dorsal splinting, and modified sugar-tong splinting.
Nonoperative immobilization of fractures can be accomplished by several methods, including circumferential casting, volar-dorsal splinting, and modified sugar-tong splinting. Researchers compared the efficacy of the three techniques in a prospective randomized study of 101 adult patients who presented to an emergency department (ED) in Vancouver, British Columbia, with closed isolated first-time distal radius fractures and who did not have neuromuscular deficit. Patients were randomized after successful reduction with procedural sedation in the ED.
Eighty-two percent of patients were available for follow-up assessment at 8 weeks, and 61% were available at 6 months. At both time points, rate of loss of anatomic position; disability of the arm, shoulder, and hand (DASH) scores; and median pain scores were similar among the three groups.
Comment: A common emergency medicine admonition is "don't put a circular cast on a fresh fracture" because of the risk for pressure syndromes. Yet circular casting is still used in some cases because it is believed to provide better immobilization than other techniques. This study failed to demonstrate better outcomes with casting, and risking compartment syndrome — even if the risk is small — is not advisable. Simple volar-dorsal or modified sugar-tong techniques are both acceptable forms of immobilization after reduction; circular casting adds risk but no benefit.
— Kristi L. Koenig, MD, FACEP. Published in Journal Watch Emergency Medicine July 9, 2010
Citation(s): Grafstein E et al. A prospective randomized controlled trial comparing circumferential casting and splinting in displaced Colles fractures. CJEM 2010 May; 12:192. http://www.cjem-online.ca/v12/n3/p192
7. Alarming Rise in Major Complications from Button Battery Ingestions
Ingestion of large button batteries, particularly lithium cells, accounts for the increase in poor outcomes.
To describe recent trends in button battery ingestions, investigators collected data from the National Poison Data System (NPDS; 56,535 cases reported during 1985–2009), the National Battery Ingestion Hotline (NBIH; 8161 cases during 1990–2008), and all 73 major (life-threatening or disabling) and 13 fatal cases ever reported in the medical literature or to the NBIH.
NPDS data showed no consistent trend in annual frequency of button battery ingestions. However, the proportion of major or fatal cases increased 6.7-fold between the first 3 years (1985–1987) and last 3 years (2007–2009). Children younger than 6 years accounted for 68% of NPDS cases and 62% of NBIH cases; all NBIH fatalities and 85% of major cases were in patients younger than 4 years. In logistic regression analysis of NBIH data, predictors of poor outcome were large battery diameter (20–25 mm; odds ratio, 24.6), age below 4 years (OR, 3.2), and ingestion of more than one battery (OR, 2.1).
During 2000–2009, 92% of major and fatal cases were from ingestion of 20-mm lithium cells. Injuries (e.g., severe burns, esophageal stenosis, bilateral vocal cord paralysis) occurred as soon as 2 hours after ingestion. Most major and fatal cases occurred in children less than 4 years old (92%) and were unwitnessed (56%), and many unwitnessed cases were initially misdiagnosed (46%). The authors present a management algorithm that recommends endoscopic removal of esophageal button batteries within 2 hours of ingestion.
Comment: These data are sobering. Physicians should keep button cells high on the list of differential diagnoses for any child who presents with airway obstruction or wheezing, drooling, vomiting, chest discomfort, difficulty swallowing or refusal to eat, or choking or coughing while eating or drinking. Once an esophageal button battery is identified, consultants must be mobilized for emergent removal.
— Katherine Bakes, MD. Published in Journal Watch Emergency Medicine June 25, 2010. Citation: Litovitz T et al. Emerging battery-ingestion hazard: Clinical implications. Pediatrics 2010 Jun; 125:1168.
8. Dorsal digital anaesthesia: one injection or two?
Cannon B, et al. Emerg Med J 2010;27:533-536.
Background: Digital nerve blocks (DNB) are performed frequently in the Emergency Department (ED). The aim of this study was to establish whether single injection subcutaneous digital nerve block (SDNB) is as effective as the traditional (two injection) digital nerve block (TDNB) for digital anaesthesia.
Method: Single blinded, prospective, randomised-controlled multicentre trial within Hampshire EDs. Patients ≥16 years attending the ED with fingertip injuries/infections (distal to the distal-interphalangeal joint) requiring a DNB were randomised to SDNB/TDNB groups. Outcome measures were: primary - successful anaesthesia; secondary - patient distress, clinician satisfaction (CS), complications.
Results: 76 patients were randomised. (37 received SDNB). At 5 min, more patients in the SDNB group (28/37, 76%) were adequately anaesthetised than in the TDNB group, (22/34, 65%). At 10 min, 33/37 (89%) of the SDNB group compared to 28/34 (82%) of the TDNB group were adequately anaesthetised. The mean (SD) of self-reported distress scores for the SDNB group were lower than those reported for the TDNB group, whereas the mean (SD) of CS scores for SDNB were higher than those reported for TDNB. Neither group reported complications from anaesthesia.
Conclusions: SDNB is as effective as TDNB. Outcome measures favoured SDNB, but only CS scores achieved statistical significance. Trial recruitment is much slower than anticipated. However, clinical practice has demonstrated that SDNB works and practice is already changing within the Hampshire region, with some departments adopting SDNB as standard practice. Therefore, the results are being presented now to allow clinicians to make an informed choice. Our results may also contribute to future metanalyses.
Editor’s note: Not compared was the one-shot transthecal block, which I find ‘handy’. For a good review, see Hart RG, et al. Transthecal digital block: an underutilized technique in the ED. Amer J Emerg Med. 2005;23:340-342. http://www.ajemjournal.com/article/S0735-6757(04)00267-0/abstract
9. Bedside Ultrasound Diagnosis of Clavicle Fractures in the Pediatric Emergency Department
Cross KP, et al. Acad Emerg Med. 2010;17:687–693.
Objectives: Clavicle fractures are among the most common orthopedic injuries in children. Diagnosis typically involves radiographs, which expose children to radiation and may consume significant time and resources. Our objective was to determine if bedside emergency department (ED) ultrasound (US) is an accurate alternative to radiography.
Methods: This was a prospective study of bedside US for diagnosing clavicle fractures. A convenience sample of children ages 1–18 years with shoulder injuries requiring radiographs was enrolled. Bedside US imaging and an unblinded interpretation were completed by a pediatric emergency physician (EP) prior to radiographs. A second interpreter, a pediatric EP attending physician with extensive US experience, determined a final interpretation of the US images at a later date. This final interpretation was blinded to both clinical and radiography outcomes. The reference standard was an attending radiologist's interpretation of radiographs. The primary outcome was the accuracy of the blinded US interpretation for detecting clavicle fractures compared to the reference standard. Secondary outcome measures included the interrater reliability of the unblinded bedside and the blinded physicians' interpretations and the FACES pain scores (range, 0–5) for US and radiograph imaging.
Results: One-hundred patients were included in the study, of whom 43 had clavicle fractures by radiography. The final US interpretation had 95% sensitivity (95% confidence interval [CI] = 83% to 99%) and 96% specificity (95% CI = 87% to 99%), and overall accuracy was 96%, with 96 congruent readings. Positive and negative predictive values (PPVs and NPVs, respectively) were 95% (95% CI = 83% to 99%) and 96% (95% CI = 87% to 99%), respectively. Interrater reliability (kappa) was 0.74 (95% CI = 0.60 to 0.88). FACES pain scores were available for the 86 subjects who were at least 5 years old. Pain scores were similar during US and radiography.
Conclusions: Compared to radiographs, bedside US can accurately diagnose pediatric clavicle fractures. US causes no more discomfort than radiography when detecting clavicle fractures. Given US's advantage of no radiation, pediatric EPs should consider this application.
10. New Study Finds 91% of Physicians Practice Defensive Medicine
Mark Crane. June 28, 2010 — The fear of being sued for medical malpractice is pervasive, leading 91% of physicians across all specialty lines to practice defensive medicine — ordering more tests and procedures than necessary to protect themselves from lawsuits — a new study finds.
A survey by researchers from Mount Sinai School of Medicine, New York City, also found that the same overwhelming percentage of physicians believe that tort reform measures to provide better protections against unwarranted malpractice suits are needed before any significant decrease in the ordering of unnecessary medical tests can be achieved.
Investigators questioned 2416 physicians from a variety of practice and specialty backgrounds in a survey conducted between June 25, 2009, and October 31, 2009. Their findings were published today in the June 28 issue of the Archives of Internal Medicine.
"Physicians feel they are vulnerable to malpractice lawsuits even when they practice competently within the standard of care," said Tara Bishop, MD, associate, Division of General Internal Medicine at Mount Sinai School of Medicine, and coauthor of the study, in a news release. "The study shows that an overwhelming majority of physicians support tort reform to decrease malpractice lawsuits and that unnecessary testing, a contributor to rising healthcare costs, will not decrease without it."
Physicians were asked to rate their level of agreement to 2 statements:
• "Doctors order more tests and procedures than patients need to protect themselves against malpractice suits," and
• "Unnecessary use of diagnostic tests will not decrease without protections for physicians against unwarranted malpractice suits."
There were no statistically significant differences between sex, geographic location, specialty category, or type of practice. The largest difference was that 92.6% of male physicians said they practice defensive medicine vs 86.5% of female physicians.
Although physicians in relatively low-risk specialties such as general internal medicine and pediatrics are much less likely to be sued for malpractice than obstetric/gynecologic specialists and emergency physicians, their fear is just as real, Dr. Bishop asserted in an interview with Medscape Medical News. "There's just a visceral response to the word 'malpractice,' " she said. "The entire medical community worries about being pulled into a lawsuit."
Determining the true costs of defensive medicine may be impossible because so many factors go into decisions about ordering tests, Dr. Bishop noted. Malpractice fears play a large role, but so does a desire to be thorough and careful. In a fee-for-service system that often rewards overuse, it is difficult to say how large a part defensive medicine plays in the decision to order a test.
A 2003 study by the US Department of Health and Human Services estimated the cost of defensive medicine at $60 billion a year, but the American Medical Association pegs it at $200 billion. A 2008 study by PricewaterhouseCoopers' Health Research Institute calculated the cost of defensive medicine at $210 billion per year, or 10% of all healthcare spending.
The new Mt. Sinai study coincides with several earlier surveys about how prevalent defensive medicine is. Some of the findings of those studies follow here.
• Ninety percent of physicians said they practice defensive medicine, according to a poll published in April by Jackson Healthcare, a medical staffing and information technology company. About three quarters of physicians surveyed said defensive medicine decreases patient access to healthcare and will exacerbate the growing physician shortage.
• A 2008 study by the Massachusetts Medical Society found that 83% of its physicians practice defensive medicine at a cost of at least $1.4 billion a year in that state alone. More than 20% of x-rays, computed tomography scans, magnetic resonance images, and ultrasounds; 18% of laboratory tests; 28% of specialty referrals; and 13% of hospital admissions were ordered for defensive purposes.
• A survey of 824 Pennsylvania physicians, published in 2005 in the Journal of the American Medical Association, found that 93% admit to risk-aversion tactics such as over-ordering tests, abandoning high-risk procedures, and avoiding the sickest of patients.
"We practice maximalist medicine to avoid missing any problem our clinical judgment tells us may be extremely remote," said Alan C. Woodward, MD, an emergency physician and past president of the Massachusetts Medical Society, to Medscape Medical News. Defensive medicine is rampant because "the threat of being sued is pervasive, and doctors simply don't trust the legal system."
In an invited commentary accompanying the Mt. Sinai study, Sen. Orrin G. Hatch (R-UT) acknowledged that consensus on Capitol Hill about tort reform "has been an elusive commodity" because of division and partisanship. "It is my hope that, as the American people see more evidence that they are paying for redundant and unuseful medical procedures, they will demand in larger numbers that real reforms be enacted to address this problem," Sen. Hatch writes. "That is what makes studies like the one by Bishop, et al., so important."
Arch Intern Med. 2010:170:1081-1084.
11. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
Yeh RW, et al. N Engl J Med. 2010;362:2155-2165.
Background: Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction.
Methods: We identified patients 30 years of age or older in a large, diverse, community-based population who were hospitalized for incident myocardial infarction between 1999 and 2008. Age- and sex-adjusted incidence rates were calculated for myocardial infarction overall and separately for ST-segment elevation and non–ST-segment elevation myocardial infarction. Patient characteristics, outpatient medications, and cardiac biomarker levels during hospitalization were identified from health plan databases, and 30-day mortality was ascertained from administrative databases, state death data, and Social Security Administration files.
Results: We identified 46,086 hospitalizations for myocardial infarctions during 18,691,131 person-years of follow-up from 1999 to 2008. The age- and sex-adjusted incidence of myocardial infarction increased from 274 cases per 100,000 person-years in 1999 to 287 cases per 100,000 person-years in 2000, and it decreased each year thereafter, to 208 cases per 100,000 person-years in 2008, representing a 24% relative decrease over the study period. The age- and sex-adjusted incidence of ST-segment elevation myocardial infarction decreased throughout the study period (from 133 cases per 100,000 person-years in 1999 to 50 cases per 100,000 person-years in 2008, P less than 0.001 for linear trend). Thirty-day mortality was significantly lower in 2008 than in 1999 (adjusted odds ratio, 0.76; 95% confidence interval, 0.65 to 0.89).
Conclusions: Within a large community-based population, the incidence of myocardial infarction decreased significantly after 2000, and the incidence of ST-segment elevation myocardial infarction decreased markedly after 1999. Reductions in short-term case fatality rates for myocardial infarction appear to be driven, in part, by a decrease in the incidence of ST-segment elevation myocardial infarction and a lower rate of death after non–ST-segment elevation myocardial infarction.
12. Images in Emergency Medicine
Rattlesnake Envenomation
http://content.nejm.org/cgi/content/full/362/23/2212
Cutis Marmorata in Decompression Sickness
http://content.nejm.org/cgi/content/full/362/23/e67
Visible Peristalsis
http://content.nejm.org/cgi/content/full/362/24/e68
Radiologic Signs of Pneumoperitoneum
http://content.nejm.org/cgi/content/full/362/25/2410
Benign Paroxysmal Positional Vertigo
http://content.nejm.org/cgi/content/full/362/25/e70
Elderly Woman with Rectal Bleeding
http://www.annemergmed.com/article/S0196-0644(09)01282-7/fulltext
Woman with Leg Rash
http://www.annemergmed.com/article/S0196-0644(09)01448-6/fulltext
13. Predictors of important neurological causes of dizziness among patients presenting to the ED
Cheung C S K, et al. Emerg Med J 2010;27:517-521.
Objectives: Dizziness is a common presenting complaint in the emergency department (ED). This prospective study describes the incidence, causes and outcome of ED patients presenting with dizziness and tries to identify predictors of central neurological causes of dizziness.
Methods: Single-centre prospective observational study in a university teaching hospital ED in Hong Kong. All ED patients (≥18 years old) presenting with dizziness were recruited for 1 month. Symptoms, previous health, physical findings, diagnosis and disposition were recorded. The outcome at 3 months was evaluated using hospital records and telephone interviews. Follow-up was also performed at 55 months using computerised hospital records to identify patients with subsequent stroke and those who had died.
Results: 413 adults (65% female, mean 57 years) were recruited. The incidence of dizziness was 3.6% (413/11 319). Nausea and/or vomiting (46%) and headache (20%) were the commonest associated findings. Hypertension (33%) was the commonest previous illness. Central neurological causes of dizziness were found in 6% (23/413) of patients. Age 65 years or greater (OR=6.13, 95% CI 1.97 to 19.09), ataxia symptoms (OR=11.39, 95% CI 2.404 to 53.95), focal neurological symptoms (OR=11.78, 95% CI 1.61 to 86.29), and history of previous stroke (OR=3.89, 95% CI 1.12 to 13.46) and diabetes mellitus (OR=3.57, 95% CI 1.04 to 12.28) predicted central causes of dizziness.
Conclusions: Most dizzy patients had benign causes. Several clinical factors favoured a diagnosis of central neurological causes of dizziness.
14. Steroid Dosage and Route in Patients Admitted for Chronic Obstructive Pulmonary Disease
Oral low-dose use was associated with less treatment failure than was high-dose parenteral use.
Patients admitted for chronic obstructive pulmonary disease (COPD) usually receive systemic steroids, which have been associated with better outcomes in several prior randomized trials, but the best dose is still in question. Several major clinical practice guidelines recommend low-dose oral steroids.
In a retrospective cohort study, based on data from 414 U.S. hospitals, Massachusetts investigators compared outcomes in nearly 80,000 patients admitted for COPD to non–intensive care unit settings. About 74,000 received parenteral steroids (equivalent to a median dose of 600 mg of prednisone total for the first 2 days), and the rest received oral prednisone (median, 60 mg for the first 2 days). Treatment failure — defined as need for mechanical ventilation after the first 2 days, death, or readmission for COPD within 30 days — occurred in 11% of all patients.
In analyses adjusted for about 50 clinical and demographic variables, as well as propensity scores, treatment failure was 16% lower in patients who received oral low-dose steroids than in those who received parenteral steroids; length of stay and cost were about 10% lower in the low-dose group.
Comment: Although this study was retrospective, its sophisticated analyses convinced editorialists that the results should influence clinical practice and that a randomized controlled trial would be prohibitive in size and cost and is unnecessary. A worrisome secondary finding is that the vast majority of COPD patients received high-dose parenteral steroids, despite the contrary recommendations of major national and international guidelines — including those of the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
— Thomas L. Schwenk, MD. Published in Journal Watch General Medicine June 24, 2010.
Citation: Lindenauer PK et al. JAMA 2010;303:2359.
15. Are 2 smaller intravenous catheters as good as 1 larger intravenous catheter?
Li SF, et al. Amer J Emerg Med. 2010;28:724-727.
Objective: Using Poiseuille's law and standardized gauge sizes, an 18-gauge (g) intravenous catheter (IV) should be 2.5 times faster than a 20-g IV, but this is not borne out by observation, in vitro testing, and manufacturer's data. Our objective was to determine if the infusion rate of a single 18-g IV was equivalent to the infusion rate of two 20-g IVs.
Methods: This was a prospective study in healthy adult volunteers. Subjects simultaneously received 500 mL of normal saline via an 18-g IV in one arm and 500 mL of normal saline via two 20-g IVs in the other arm. We measured the rates of fluid administration. Paired Student's t test was used for comparison of the 2 arms of the study. We estimated that 18 trials were needed in sample size analysis.
Results: Eighteen trials were completed. The mean infusion rate for a single 18-g 500-mL IV administration was 35.6 mL/min (95% confidence interval [CI], 30.3-40.8), with manufacturer's rating being 105 mL/min. The mean infusion rate for two 20-g IVs was 41.3 mL/min (95% CI, 36.1-46.4), with manufacturer's rating being 120 mL/min. The rate of infusion via two 20-g IVs were statistically significantly faster than the single 18-g IV, with a mean difference in flow rate of 5.7 mL/min (95% CI, 1.3-10; P = .026).
Conclusion; In healthy volunteers, administration of intravenous fluids through two 20-g IVs is faster than a single 18-g IV, although both approaches are markedly slower than the manufacturer's estimates.
16. Are routine repeat chest x-rays before leaving the trauma room useful?
Lemmers M, et al. Emerg Med J 2010;27:522-525.
Background: Several guidelines advocate multiple chest x-rays during primary resuscitation of trauma patients. Some local hospital protocols include a repeat x-ray before leaving the trauma resuscitation room (TR). The purpose of this study was to determine the value of routine repeat x-rays.
Methods: One-year data of all radiological imaging in the TR were prospectively collected for all patients presenting to the TR of the hospital. The x-rays were counted and assessed and the findings were classified as either ‘new injury detected’, ‘presence of intervention devices’ or ‘deterioration of previously detected injury’.
Results: A total of 674 patients were included. More than 75% had two x-rays. Eight (2.1%) new injuries without clinical relevance were found on the repeat x-ray after an initial normal x-ray. 61 patients (9%) had a repeat x-ray to verify the effect of an intervention or position of devices. In 28 patients (22%) with two abnormal x-rays, newly diagnosed injuries (n=9) or deterioration of known injuries (n=19) were found. In 411 patients (81%) the results of the repeat x-ray had no clinical consequences.
Conclusion: This study indicates that routine repeat chest x-rays can be omitted in trauma patients whose initial chest x-ray is normal.
17. Normal Renal Ultrasound Might Obviate Need for Computed Tomography in Suspected Urolithiasis
Patients with normal renal ultrasound results had a low rate of urologic intervention within 90 days.
Edmonds ML, et al. CJEM 2010;12:201-206.
Objective: Computed tomography (CT) is an imaging modality used to detect renal stones. However, there is concern about the lifetime cumulative radiation exposure attributed to CT. Ultrasonography (US) has been used to diagnose urolithiasis, thereby avoiding radiation exposure. The objective of this study was to determine the ability of US to identify renal colic patients with a low risk of requiring urologic intervention within 90 days of their initial emergency department (ED) visit.
Methods: We completed a retrospective medical record review for all adult patients who underwent ED-ordered renal US for suspected urolithiasis over a 1-year period. Independent, double data extraction was performed for all imaging reports and US results were categorized as “normal,” “suggestive of ureterolithiasis,” “ureteric stone seen” or “disease unrelated to urolithiasis.” Charts were reviewed to determine how many patients underwent subsequent CT and urologic intervention.
Results: Of the 817 renal US procedures ordered for suspected urolithiasis during the study period, the results of 352 (43.2%) were classified as normal, and only 2 (0.6%) of these patients required urologic intervention. The results of 177 (21.7%) renal US procedures were suggestive of ureterolithiasis. Of these, 12 (6.8%) patients required urologic intervention. Of the 241 (29.5%) patients who had a ureteric stone seen on US, 15 (6.2%) required urologic intervention. The rate of urologic intervention was significantly lower in those with normal results on US (p less than 0.001) than in those with abnormal results on US.
Conclusion: A normal result on renal US predicts a low likelihood for urologic intervention within 90 days for adult ED patients with suspected urolithiasis.
18. The Importance of Being Timely (with regard to reperfusion)
In a population-based cohort with ST-segment-elevation myocardial infarction, time to reperfusion had a stronger effect than method of reperfusion on outcomes.
Lambert L, et al. JAMA. 2010;303:2148-55.
CONTEXT: Guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI) and specify a maximum delay of 30 minutes for fibrinolysis and 90 minutes for primary percutaneous coronary intervention (PPCI). However, randomized trials and selective registries are limited in their ability to assess the effect of timeliness of reperfusion on outcomes in real-world STEMI patients.
OBJECTIVES: To obtain a complete interregional portrait of contemporary STEMI care and to investigate timeliness of reperfusion and outcomes.
DESIGN, SETTING, AND PATIENTS: Systematic evaluation of STEMI care for 6 months during 2006-2007 in 80 hospitals that treated more than 95% of patients with acute myocardial infarction in the province of Quebec, Canada (population, 7.8 million).
MAIN OUTCOME MEASURES: Death at 30 days and at 1 year and the combined end point of death or hospital readmission for acute myocardial infarction or congestive heart failure at 1 year by linkage to Quebec's medicoadministrative databases.
RESULTS: Of 1832 patients treated with reperfusion, 392 (21.4%) received fibrinolysis and 1440 (78.6%) received PPCI. Fibrinolysis was untimely (beyond 30 minutes) in 54% and PPCI was untimely (beyond 90 minutes) in 68%. Death or readmission for acute myocardial infarction or heart failure at 1 year occurred in 13.5% of fibrinolysis patients and 13.6% of PPCI patients. When the 2 treatment groups were combined, patients treated outside of recommended delays had an adjusted higher risk of death at 30 days (6.6% vs 3.3%; odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21-3.93) and a statistically nonsignificant increase in risk of death at 1 year (9.3% vs 5.2%; OR, 1.61; 95% CI, 1.00-2.66) compared with patients who received timely treatment. Patients treated outside of recommended delays also had an adjusted higher risk for the combined outcome of death or hospital readmission for congestive heart failure or acute myocardial infarction at 1 year (15.0% vs 9.2%; OR, 1.57; 95% CI, 1.08-2.30). At the regional level, after adjustment, each 10% increase in patients treated within the recommended time was associated with a decrease in the region-level odds of overall 30-day mortality (OR, 0.80; 95% CI, 0.65-0.98).
CONCLUSION: Among patients in Quebec with STEMI, reperfusion delivered outside guideline-recommend delays was associated with significantly increased 30-day mortality, a statistically nonsignificant increase in 1-year mortality, and significantly increased risk of the composite of mortality or readmission for acute myocardial infarction or heart failure at 1 year.
19. Genomic Medicine — An Updated Primer
Feero WG, et al. N Engl J Med. 2010;362:2001-2011.
Remarkable advances have been made in understanding the human genome's contribution to health and disease since the first Genomic Medicine series was launched in the Journal in 2002… Completion of the Human Genome Project in 2003 was a major driver for the current period of biomedical discovery, and the pace continues to accelerate. This project spurred the development of innovations with extraordinary benefits. Initially, clinically useful discoveries derived from the Human Genome Project yielded improvements in "genetic medicine" — that is, the use of knowledge about single genes to improve the diagnosis and treatment of single-gene disorders. However, our increased understanding of the interactions between the entire genome and nongenomic factors that result in health and disease is paving the way for an era of "genomic medicine," in which new diagnostic and therapeutic approaches to common multifactorial conditions are emerging.
As a result of genomic discoveries, increasing numbers of clinical guidelines now suggest incorporating genomic tests or therapeutics into routine care. In some cases, the rapidity of translation has sparked debate regarding the level of evidence of clinical benefit needed to introduce new, and potentially costly, medical technologies. Although the effect of genomic discovery on the day-to-day practice of medicine has not been well quantified, it probably remains small in primary care and nonacademic settings as compared with, for example, oncology practice in an academic medical center. Regardless of where medicine is practiced, genomics is inexorably changing our understanding of the biology of nearly all medical conditions….
Given the diversity of the human species, there is no "normal" human genome sequence. We are all mutants. [Editor's note: My limited experience confirms that.]
Full-text (free): http://content.nejm.org/cgi/content/full/362/21/2001
20. Immediate β-Blockade in Patients with Myocardial Infarctions: Is There Evidence of Benefit?
Sinert R, et al. Ann Emerg Med. 2010; in press
Study Objective
The American Heart Association recommends the initiation of β-blockade to all patients with an ST-segment elevation myocardial infarction (STEMI) without contraindications to β-blocking agents. The present study seeks to systematically review the medical literature to determine the efficacy of treating STEMI patients with a β-blocker within the first 24 hours.
Methods
We searched databases for articles through MEDLINE with the PubMed interface and from 1966 through May 2009 and EMBASE from 1980 to August 2009 with the Ovid Technologies interface, using a search strategy derived from the following PICO (Patient-Intervention-Comparator-Outcome) clinical question: In patients presenting with STEMI (P), does immediate treatment with β-blockers (I) followed by standardized care beginning on day 2 or 3 compared with placebo or no treatment followed by standardized care on day 2 or 3 (C) reduce the risk of death, reinfarction, or cardiogenic shock (O)? The methodological quality of the studies was assessed.
Results
From more than 2,000 references identified in the search, only a single randomized trial met the inclusion criteria. There were no statistically significant differences in mortality; the relative risk for the combined endpoint (mortality and reinfarction) was 0.67 (95% confidence interval 0.44 to 1.03) at 6 days and 0.74 (95% confidence interval 0.53 to 1.06) at 6 weeks. Outcomes for cardiogenic shock were not reported.
Conclusion
Evidence from a single randomized trial failed to demonstrate a reduction in mortality or reinfarction with administration of β-blocker within the first 24 hours after STEMI.
21. U.S. Scores Dead Last Again in Healthcare Study
By Maggie Fox. WASHINGTON (Reuters) Jun 23 - Americans spend twice as much as residents of other developed countries on healthcare, but get lower quality, less efficiency and have the least equitable system, according to a report released on Wednesday.
The United States ranked last when compared to six other countries -- Britain, Canada, Germany, Netherlands, Australia and New Zealand, the Commonwealth Fund report found.
"As an American it just bothers me that with all of our know-how, all of our wealth, that we are not assuring that people who need healthcare can get it," Commonwealth Fund president Karen Davis told reporters in a telephone briefing.
Previous reports by the nonprofit Fund, which conducts research into healthcare performance and which promotes changes in the U.S. system, have been heavily used by policymakers and politicians pressing for healthcare reform.
Davis said she hoped health reform legislation passed in March would lead to improvements.
The current report uses data from nationally representative patient and physician surveys in seven countries in 2007, 2008, and 2009.
In 2007, health spending was $7,290 per person in the United States, more than double that of any other country in the survey.
Australians spent $3,357, Canadians $3,895, Germans $3,588, the Netherlands $3,837 and Britons spent $2,992 per capita on health in 2007. New Zealand spent the least at $2,454.
And yet Americans get less for their money, said the Commonwealth Fund's Cathy Schoen.
"We rank last on safety and do poorly on several dimensions of quality," Schoen told reporters. "We do particularly poorly on going without care because of cost. And we also do surprisingly poorly on access to primary care and after-hours care."
The report looks at five measures of healthcare -- quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives.
"On measures of quality the United States ranked 6th out of seven countries," the group said in a statement.
U.S. patients with chronic conditions were the most likely to say they got the wrong drug or had to wait to learn of abnormal test results.
Overall Britain, whose nationalized healthcare system was widely derided by opponents of U.S. healthcare reform, ranks second, the Commonwealth team found. The Netherlands ranked first.
"The findings demonstrate the need to quickly implement provisions in the new health reform law and stimulus legislation that focus on strengthening primary care, realigning incentives to reward higher quality and greater value, investing in preventive care, and expanding the use of health information technology," the report reads.
Critics of reports that show Europeans or Australians are healthier than Americans point to the U.S. lifestyle as a bigger factor than healthcare. Americans have higher rates of obesity than other developed countries, for instance.
"On the other hand, the other countries have higher rates of smoking," Davis countered. And Germany, for instance, has a much older population more prone to chronic disease.
Every other system covers all its citizens, the report noted and said the U.S. system, which leaves 46 million Americans or 15% of the population without health insurance, is the most unfair.
"The lower the performance score for equity, the lower the performance on other measures. This suggests that, when a country fails to meet the needs of the most vulnerable, it also fails to meet the needs of the average citizen," the report reads.
Cf: http://www.commonwealthfund.org/Content/Publications/Fund-Reports/2010/Jun/Mirror-Mirror-Update.aspx
1. Typical Angina vs. Atypical Chest Pain
In patients presenting to an emergency department, presence and type of symptoms did not predict inducible myocardial ischemia.
Hermann LK, et al. Am J Cardiol. 2010;105:1561-4.
The present study was designed to assess the value of the presenting symptom of "typical" anginal pain, "atypical/nonanginal" pain, or the lack of chest pain in predicting the presence of inducible myocardial ischemia using cardiac stress testing in emergency department patients being evaluated for possible acute coronary syndrome.
We performed a retrospective observational study of adult patients who were evaluated for acute coronary syndrome in an emergency department chest pain unit. The presenting symptoms were obtained from a structured questionnaire administered before stress testing. Patient chest pain was categorized according to the presence of substernal chest pain or discomfort that was provoked by exertion or emotional stress and was relieved by rest and/or nitroglycerin. Chest pain was classified as "typical" angina if all 3 descriptors were present and "atypical" or "nonanginal" if less than 3 descriptors were present. All patients underwent serial biomarker and cardiac stress testing before discharge.
A total of 2,525 patients met the eligibility criteria. Inducible ischemia on stress testing was found in 33 (14%, 95% confidence interval 10% to 19%) of the 231 patients who had typical anginal pain, 238 (11%, 95% confidence interval 10% to 13%) of the 2,140 patients presenting with atypical/nonanginal chest pain, and 25 (16%, 95% confidence interval 11% to 22%) of the 153 patients who had no complaint of chest pain on presentation. Compared to patients with atypical or no chest pain, patients with typical chest pain were not significantly more likely to have inducible ischemia on stress testing (likelihood ratio +1.25, 95% confidence interval 0.89 to 1.78).
In conclusion, in our study, the patients who presented with "typical" angina were no more likely to have inducible myocardial ischemia on stress testing than patients with other presenting symptoms.
2. Dramatic Increase in ED Visits Resulting From Prescription Opioid Use
Deborah Brauser. June 29, 2010 — The estimated number of emergency department (ED) visits involving nonmedical use of prescription opioids increased by 111% during a 5-year period, according to a new study by researchers from the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
Oxycodone, hydrocodone, and methadone products were the opioid pain relievers most frequently involved in these visits, with increases of 152%, 123%, and 73%, respectively.
"These alarming findings provide 1 more example of how the misuse of prescription pain relievers is impacting lives and our health care system," said Pamela S. Hyde, JD, administrator of SAMSHA, Rockville, Maryland, in a statement. "This public health threat requires an all-out effort to raise awareness of the public about proper use, storage, and disposal of these powerful drugs."
"We urgently need to take action," echoed Thomas R. Frieden, MD, MPH, director of the CDC in Atlanta, Georgia, in the same statement. "ED visits involving non-medical use of these prescription drugs are now as common as ED visits for use of illicit drugs. These prescription medicines help many people, but we need to be sure they are used properly and safely."
The findings were reported jointly in a SAMHSA survey report and in the CDC's Morbidity and Mortality Weekly Report, published online June 17.
Important Public Health Issue
"This is something we've been tracking for a number of years, and it's been pretty clear that prescription drug use has been growing over time," Peter Delany, PhD, director of the Office of Applied Studies at SAMSHA, told Medscape Psychiatry. "This [study] was an opportunity for us to work with our partners at CDC to look at 5 years worth of data and to track trends.
"It was a real collaboration with our colleagues at CDC and we were very happy to do it as a joint project, especially because this is a critically important public health issue," added Dr. Delany.
The investigative team evaluated a "stratified, simple random sample" from 220 hospitals with 24-hour EDs between the years 2004 and 2008 from SAMHSA's Drug Abuse Warning Network ED system.
Nonmedical use of a prescription drug was defined as "taking a higher-than-recommended dose, taking a drug prescribed for another person, drug-facilitated assault, or documented misuse or abuse," according to the study authors.
Dramatic Increases
Results showed that the nonmedical use of prescription opioids rose significantly from 144,600 ED visits in 2004 to 305,900 visits in 2008 (P less than .001). It also increased by 29% just between the years 2007 and 2008.
In addition, ED visits during the 5-year period involving nonmedical oxycodone use rose significantly from 41,700 to 105,214 visits a year (P less than .001). Hydrocodone involvement rose from 39,844 to 89,051 visits, and methadone product involvement rose from 36,806 to 63,629 visits.
These increases "reflect, in part, substantial increases in the prescribing of these classes of drugs," the investigators write.
When researchers also looked at the estimated number of nonmedical benzodiazepine-related ED visits, they found an overall increase by 89% between 2004 and 2008 (from 143,500 to 271,700 visits; P = .01).
Individual benzodiazepines also showed significant rises in ED visits during the study period, including a 125% increase for alprazolam (P = .01), 107% increase for lorazepam (P = .006), 72% increase for clonazepam (P less than .001), and 70% increase for diazepam (P = .02). Benzodiazepines were involved in 26% of all opioid-related visits.
Age-specific rates of ED visits in 2008 showed a sharp increase for both opioids and benzodiazepines "after age 17 years, [peaking] in the 21 to 24 years age group, and [declining] after age 54 years," report the study authors. "The largest increases during 2004 to 2008 occurred among persons aged 21 to 29."
Although women had more benzodiazepine-related ED visits than men in 2008 (152,100 vs 119,600, respectively), the difference was not statistically significant.
"These findings indicate substantial, increasing morbidity associated with the nonmedical use of prescription drugs...despite recent efforts to control the problem," write the study authors. "Stronger measures to reduce the diversion of prescription drugs to nonmedical purposes are warranted."
Opportunity for Prevention and Education
"I think the number 1 takeaway is that this is an opportunity for [clinicians] to really think about these findings and then talk about them with their patients," said Dr. Delany. "It's also an opportunity for prevention and education. How do you store and dispose of medications when you don't need them anymore? These answers need to be given not just by the clinician who is prescribing medications but also by pharmacists and other health providers. Also, adults need to be aware of what's going on in their medicine cabinets, especially if there are [young people] in the household."
"The abuse of prescription drugs is our nation's fastest-growing drug problem. And this new study shows it is a problem that affects men and women, people under 21, and those over 21," said R. Gil Kerlikowske, director of the Office of National Drug Control Policy in Rockville, Maryland, in a statement.
"The newly released National Drug Control Strategy contains specific steps that all of us can take to address this issue," added Director Kerlikowske.
Dr. Delany noted that SAMHSA and the CDC plan on participating in more joint research partnerships. "There's a real commitment between my administrator and Dr. Frieden at CDC to keep building on the collaborations that we have done over the years.
"We're a behavioral health statistical unit while their researchers really look at health areas. So the ability to bring behavioral health and health together for these types of mainstream health issues is important, especially because they're both so intertwined," said Dr. Delany.
The study authors and commentators have disclosed no relevant financial relationships.
SAMHSA. "The DAWN Report — Trends in Emergency Department Visits Involving Nonmedical Use of Narcotic Pain Relievers." Released June 18, 2010. http://www.oas.samhsa.gov/2k10/DAWN016/OpioidED.htm
Morb Mortal Wkly Rep. "ED Visits Involving Nonmedical Use of Selected Prescription Drugs." Published online June 17, 2010. http://www.cdc.gov/mmwr/pdf/wk/mm5923.pdf
3. The Impact of Delays to Admission from the ED on Inpatient Outcomes
Huang Q, et al. BMC Emerg Med 2010, 10:16doi:10.1186/1471-227X-10-16
Background
We sought to determine the impact of delays to admission from the Emergency Department (ED) on inpatient length of stay (LOS), and IP cost.
Methods
We conducted a retrospective analysis of 13,460 adult (18 yrs and up) ED visits between April 1 2006 and March 30 2007 at a tertiary care teaching hospital with two ED sites in which the mode of disposition was admission to ICU, surgery or inpatient wards. We defined ED Admission Delay as ED time to decision to admit greater than 12 hours. The primary outcomes were IP LOS, and total IP cost.
Results
Approximately 11.6% (n=1558) of admitted patients experienced admission delay. In multivariate analysis we found that admission delay was associated with 12.4% longer IP LOS (95 % CI 6.6% - 18.5%) and 11.0% greater total IP cost (6.0% - 16.4%). We estimated the cumulative impact of delay on all delayed patients as an additional 2,183 inpatient days and an increase in IP cost of $2,109,173 at the study institution.
Conclusions
Delays to admission from the ED are associated with increased IP LOS and IP cost. Improving patient flow through the ED may reduce hospital costs and improve quality of care. There may be a business case for investments to reduce emergency department admission delays.
Full-text (free): http://www.biomedcentral.com/content/pdf/1471-227x-10-16.pdf
4. Is Computed Tomography Safe?
Rebecca Smith-Bindman, M.D. N Engl J Med. 2010;published online (10.1056/NEJMp1002530)
Ms. C., a 59-year-old schoolteacher, awoke on September 8, 2009, with facial paralysis. In a local emergency room [sic], she underwent computed tomographic (CT) and magnetic resonance imaging (MRI) brain scanning. The scans were normal, Bell's palsy was diagnosed, and the symptoms resolved over the next few weeks. Two weeks later, Ms. C. began losing her hair in a band-like distribution, and the following week she awoke with vertigo and confusion and returned to the emergency room, where repeat CT and MRI scans were normal. Fatigue, malaise, memory loss, and confusion began soon thereafter and have continued, making it difficult for her to work. Review of the first CT scan revealed that she had received a radiation dose to her brain of 6 Gy — approximately 100 times the dose from the average brain CT scan, 10 times the dose from the average brain-perfusion scan, and 3 times the daily dose of radiation treatment for brain cancer. Ms. C. is now a plaintiff in both a federal class-action lawsuit against a CT-scanner manufacturer and a state medical malpractice lawsuit. More than 378 patients in the United States have been identified as having received brain-perfusion scans with similar radiation overdoses, and the Food and Drug Administration (FDA) has issued a national advisory that hospitals should carefully check their CT protocols.
Radiation doses from CT scans are 100 to 500 times those from conventional radiography, depending on what part of the body is imaged. CT-machine manufacturers compete, in part, on the basis of image quality, which is directly associated with radiation dose (see figure). Technical advances such as increased imaging speed have led to new CT scanning techniques that have also boosted doses. For example, the brain-perfusion scan undergone by Ms. C. uses sophisticated techniques for assessing regional blood flow and, even when done correctly, delivers a dose 10 times that of a routine brain CT. Although such imaging techniques may have a role in diagnosis, there are few evidence-based guidelines regarding their appropriate use, and institutional use varies widely, reflecting physicians' preferences and manufacturers' promotion of these capabilities, rather than scientific evidence of improved clinical outcomes. Ms. C. not only received an accidental radiation overdose but also underwent a high-dose brain-perfusion CT when a much-lower-dose, routine head CT would have sufficed.
The rest of the article: Full-text (free): http://content.nejm.org/cgi/content/full/NEJMp1002530
5. Families Don't Trust Bad News from ICU Doctors
By Amy Norton. NEW YORK (Reuters Health) Jul 01 - Families of critically ill patients may often take a more optimistic view of their loved one's condition than doctors do, even when they are given a specific estimate of the chances of survival, a new study suggests.
A number of studies have found that doctors and family members frequently have different opinions on critically ill patients' odds of survival. This raises the question of whether doctors are effectively communicating their estimates of patients' prognosis.
Many experts now recommend that doctors try to give specific numeric estimates of a patient's chances of survival -- rather than "qualitative" information, such as telling families is it "very unlikely" that their loved one will survive.
So for the new study, researchers looked at whether the numeric and qualitative approaches differed in their effects on families' views.
The researchers had 169 family members of patients treated in one intensive care unit view videos that portrayed a doctor discussing a critically ill patient's prognosis with the family.
Half the family members viewed a hypothetical scenario in which the doctor told the family that their relative was "very unlikely" to survive and "very likely" to die. The doctor also said that if he did live, he would probably have to remain on a ventilator. The other half of the family members saw a video with the same scenario, with the exception that the doctor said the patient had a 10% chance of surviving and a 90% chance of dying.
In both cases, the researchers found, study participants came away with a more positive estimate of the hypothetical patient's prognosis than the doctor on the video had given.
They restated the doctor's estimates fairly accurately, but when asked for their own sense of the patient's chances of survival, study participants gave an average estimate of 26% after watching the video where the doctor had said survival was "very unlikely."
Even after viewing the video in which the doctor gave 10% survival odds, study participants still said the patient had, on average, a 22% chance of making it.
"The key finding is that many families don't take physicians' estimates at face value," said Dr. Douglas B. White, of the University of Pittsburgh Medical Center in Pennsylvania, who directed the study.
The findings, reported online June 10th in the American Journal of Respiratory and Critical Care Medicine, also suggest that effective communication with families is not just a matter of giving numeric estimates of the chances of survival, rather than qualitative ones.
This may mean, Dr. White said in an interview, that ICU doctors need to limit the amount of the information they convey, so that family members are less likely to be overwhelmed at a time when they are distraught. They could also try explicitly asking family members if they understood the information they were just given, he said.
Trust is another key issue, the researcher noted. ICU physicians are not the patient's or family's regular doctor, which means family members are being asked to trust the judgment of a stranger.
In this study, participants who reported relatively less trust in doctors also disagreed to a greater extent with the doctor's prognosis estimate in the video.
Dr. White said that it remains unclear exactly how ICU doctors can best establish a level of trust between themselves and family members in such a short and emotionally charged time frame.
Research also suggests that families take a number of factors into consideration, other than the doctor's judgment, when it comes to their own views of a loved one's chances of survival.
In an earlier study, Dr. White and his colleagues found that families of critically ill ICU patients only rarely relied on doctors' prognostication alone.
Instead, they often considered their perceptions of their loved one's strength and "will to live," his or her history of overcoming illness, and their own trust in optimism, intuition and faith.
As for how well doctors are able to estimate prognosis, research suggests they are "fairly accurate" when estimating the general odds of patients in a given situation surviving to hospital discharge, according to Dr. White. They are not as good, however, at predicting whether any one patient will live or die.
There is, Dr. White said, an "inherent uncertainty in medicine," and doctors need to convey that fact to family members as well.
http://ajrccm.atsjournals.org/cgi/content/abstract/201002-0262OCv1
Am J Respir Crit Care Med 2010.
6. Similar Results from Three Immobilization Techniques after Colles Fracture Reduction
Outcomes were similar at 8 weeks and at 6 months with circumferential casting, volar-dorsal splinting, and modified sugar-tong splinting.
Nonoperative immobilization of fractures can be accomplished by several methods, including circumferential casting, volar-dorsal splinting, and modified sugar-tong splinting. Researchers compared the efficacy of the three techniques in a prospective randomized study of 101 adult patients who presented to an emergency department (ED) in Vancouver, British Columbia, with closed isolated first-time distal radius fractures and who did not have neuromuscular deficit. Patients were randomized after successful reduction with procedural sedation in the ED.
Eighty-two percent of patients were available for follow-up assessment at 8 weeks, and 61% were available at 6 months. At both time points, rate of loss of anatomic position; disability of the arm, shoulder, and hand (DASH) scores; and median pain scores were similar among the three groups.
Comment: A common emergency medicine admonition is "don't put a circular cast on a fresh fracture" because of the risk for pressure syndromes. Yet circular casting is still used in some cases because it is believed to provide better immobilization than other techniques. This study failed to demonstrate better outcomes with casting, and risking compartment syndrome — even if the risk is small — is not advisable. Simple volar-dorsal or modified sugar-tong techniques are both acceptable forms of immobilization after reduction; circular casting adds risk but no benefit.
— Kristi L. Koenig, MD, FACEP. Published in Journal Watch Emergency Medicine July 9, 2010
Citation(s): Grafstein E et al. A prospective randomized controlled trial comparing circumferential casting and splinting in displaced Colles fractures. CJEM 2010 May; 12:192. http://www.cjem-online.ca/v12/n3/p192
7. Alarming Rise in Major Complications from Button Battery Ingestions
Ingestion of large button batteries, particularly lithium cells, accounts for the increase in poor outcomes.
To describe recent trends in button battery ingestions, investigators collected data from the National Poison Data System (NPDS; 56,535 cases reported during 1985–2009), the National Battery Ingestion Hotline (NBIH; 8161 cases during 1990–2008), and all 73 major (life-threatening or disabling) and 13 fatal cases ever reported in the medical literature or to the NBIH.
NPDS data showed no consistent trend in annual frequency of button battery ingestions. However, the proportion of major or fatal cases increased 6.7-fold between the first 3 years (1985–1987) and last 3 years (2007–2009). Children younger than 6 years accounted for 68% of NPDS cases and 62% of NBIH cases; all NBIH fatalities and 85% of major cases were in patients younger than 4 years. In logistic regression analysis of NBIH data, predictors of poor outcome were large battery diameter (20–25 mm; odds ratio, 24.6), age below 4 years (OR, 3.2), and ingestion of more than one battery (OR, 2.1).
During 2000–2009, 92% of major and fatal cases were from ingestion of 20-mm lithium cells. Injuries (e.g., severe burns, esophageal stenosis, bilateral vocal cord paralysis) occurred as soon as 2 hours after ingestion. Most major and fatal cases occurred in children less than 4 years old (92%) and were unwitnessed (56%), and many unwitnessed cases were initially misdiagnosed (46%). The authors present a management algorithm that recommends endoscopic removal of esophageal button batteries within 2 hours of ingestion.
Comment: These data are sobering. Physicians should keep button cells high on the list of differential diagnoses for any child who presents with airway obstruction or wheezing, drooling, vomiting, chest discomfort, difficulty swallowing or refusal to eat, or choking or coughing while eating or drinking. Once an esophageal button battery is identified, consultants must be mobilized for emergent removal.
— Katherine Bakes, MD. Published in Journal Watch Emergency Medicine June 25, 2010. Citation: Litovitz T et al. Emerging battery-ingestion hazard: Clinical implications. Pediatrics 2010 Jun; 125:1168.
8. Dorsal digital anaesthesia: one injection or two?
Cannon B, et al. Emerg Med J 2010;27:533-536.
Background: Digital nerve blocks (DNB) are performed frequently in the Emergency Department (ED). The aim of this study was to establish whether single injection subcutaneous digital nerve block (SDNB) is as effective as the traditional (two injection) digital nerve block (TDNB) for digital anaesthesia.
Method: Single blinded, prospective, randomised-controlled multicentre trial within Hampshire EDs. Patients ≥16 years attending the ED with fingertip injuries/infections (distal to the distal-interphalangeal joint) requiring a DNB were randomised to SDNB/TDNB groups. Outcome measures were: primary - successful anaesthesia; secondary - patient distress, clinician satisfaction (CS), complications.
Results: 76 patients were randomised. (37 received SDNB). At 5 min, more patients in the SDNB group (28/37, 76%) were adequately anaesthetised than in the TDNB group, (22/34, 65%). At 10 min, 33/37 (89%) of the SDNB group compared to 28/34 (82%) of the TDNB group were adequately anaesthetised. The mean (SD) of self-reported distress scores for the SDNB group were lower than those reported for the TDNB group, whereas the mean (SD) of CS scores for SDNB were higher than those reported for TDNB. Neither group reported complications from anaesthesia.
Conclusions: SDNB is as effective as TDNB. Outcome measures favoured SDNB, but only CS scores achieved statistical significance. Trial recruitment is much slower than anticipated. However, clinical practice has demonstrated that SDNB works and practice is already changing within the Hampshire region, with some departments adopting SDNB as standard practice. Therefore, the results are being presented now to allow clinicians to make an informed choice. Our results may also contribute to future metanalyses.
Editor’s note: Not compared was the one-shot transthecal block, which I find ‘handy’. For a good review, see Hart RG, et al. Transthecal digital block: an underutilized technique in the ED. Amer J Emerg Med. 2005;23:340-342. http://www.ajemjournal.com/article/S0735-6757(04)00267-0/abstract
9. Bedside Ultrasound Diagnosis of Clavicle Fractures in the Pediatric Emergency Department
Cross KP, et al. Acad Emerg Med. 2010;17:687–693.
Objectives: Clavicle fractures are among the most common orthopedic injuries in children. Diagnosis typically involves radiographs, which expose children to radiation and may consume significant time and resources. Our objective was to determine if bedside emergency department (ED) ultrasound (US) is an accurate alternative to radiography.
Methods: This was a prospective study of bedside US for diagnosing clavicle fractures. A convenience sample of children ages 1–18 years with shoulder injuries requiring radiographs was enrolled. Bedside US imaging and an unblinded interpretation were completed by a pediatric emergency physician (EP) prior to radiographs. A second interpreter, a pediatric EP attending physician with extensive US experience, determined a final interpretation of the US images at a later date. This final interpretation was blinded to both clinical and radiography outcomes. The reference standard was an attending radiologist's interpretation of radiographs. The primary outcome was the accuracy of the blinded US interpretation for detecting clavicle fractures compared to the reference standard. Secondary outcome measures included the interrater reliability of the unblinded bedside and the blinded physicians' interpretations and the FACES pain scores (range, 0–5) for US and radiograph imaging.
Results: One-hundred patients were included in the study, of whom 43 had clavicle fractures by radiography. The final US interpretation had 95% sensitivity (95% confidence interval [CI] = 83% to 99%) and 96% specificity (95% CI = 87% to 99%), and overall accuracy was 96%, with 96 congruent readings. Positive and negative predictive values (PPVs and NPVs, respectively) were 95% (95% CI = 83% to 99%) and 96% (95% CI = 87% to 99%), respectively. Interrater reliability (kappa) was 0.74 (95% CI = 0.60 to 0.88). FACES pain scores were available for the 86 subjects who were at least 5 years old. Pain scores were similar during US and radiography.
Conclusions: Compared to radiographs, bedside US can accurately diagnose pediatric clavicle fractures. US causes no more discomfort than radiography when detecting clavicle fractures. Given US's advantage of no radiation, pediatric EPs should consider this application.
10. New Study Finds 91% of Physicians Practice Defensive Medicine
Mark Crane. June 28, 2010 — The fear of being sued for medical malpractice is pervasive, leading 91% of physicians across all specialty lines to practice defensive medicine — ordering more tests and procedures than necessary to protect themselves from lawsuits — a new study finds.
A survey by researchers from Mount Sinai School of Medicine, New York City, also found that the same overwhelming percentage of physicians believe that tort reform measures to provide better protections against unwarranted malpractice suits are needed before any significant decrease in the ordering of unnecessary medical tests can be achieved.
Investigators questioned 2416 physicians from a variety of practice and specialty backgrounds in a survey conducted between June 25, 2009, and October 31, 2009. Their findings were published today in the June 28 issue of the Archives of Internal Medicine.
"Physicians feel they are vulnerable to malpractice lawsuits even when they practice competently within the standard of care," said Tara Bishop, MD, associate, Division of General Internal Medicine at Mount Sinai School of Medicine, and coauthor of the study, in a news release. "The study shows that an overwhelming majority of physicians support tort reform to decrease malpractice lawsuits and that unnecessary testing, a contributor to rising healthcare costs, will not decrease without it."
Physicians were asked to rate their level of agreement to 2 statements:
• "Doctors order more tests and procedures than patients need to protect themselves against malpractice suits," and
• "Unnecessary use of diagnostic tests will not decrease without protections for physicians against unwarranted malpractice suits."
There were no statistically significant differences between sex, geographic location, specialty category, or type of practice. The largest difference was that 92.6% of male physicians said they practice defensive medicine vs 86.5% of female physicians.
Although physicians in relatively low-risk specialties such as general internal medicine and pediatrics are much less likely to be sued for malpractice than obstetric/gynecologic specialists and emergency physicians, their fear is just as real, Dr. Bishop asserted in an interview with Medscape Medical News. "There's just a visceral response to the word 'malpractice,' " she said. "The entire medical community worries about being pulled into a lawsuit."
Determining the true costs of defensive medicine may be impossible because so many factors go into decisions about ordering tests, Dr. Bishop noted. Malpractice fears play a large role, but so does a desire to be thorough and careful. In a fee-for-service system that often rewards overuse, it is difficult to say how large a part defensive medicine plays in the decision to order a test.
A 2003 study by the US Department of Health and Human Services estimated the cost of defensive medicine at $60 billion a year, but the American Medical Association pegs it at $200 billion. A 2008 study by PricewaterhouseCoopers' Health Research Institute calculated the cost of defensive medicine at $210 billion per year, or 10% of all healthcare spending.
The new Mt. Sinai study coincides with several earlier surveys about how prevalent defensive medicine is. Some of the findings of those studies follow here.
• Ninety percent of physicians said they practice defensive medicine, according to a poll published in April by Jackson Healthcare, a medical staffing and information technology company. About three quarters of physicians surveyed said defensive medicine decreases patient access to healthcare and will exacerbate the growing physician shortage.
• A 2008 study by the Massachusetts Medical Society found that 83% of its physicians practice defensive medicine at a cost of at least $1.4 billion a year in that state alone. More than 20% of x-rays, computed tomography scans, magnetic resonance images, and ultrasounds; 18% of laboratory tests; 28% of specialty referrals; and 13% of hospital admissions were ordered for defensive purposes.
• A survey of 824 Pennsylvania physicians, published in 2005 in the Journal of the American Medical Association, found that 93% admit to risk-aversion tactics such as over-ordering tests, abandoning high-risk procedures, and avoiding the sickest of patients.
"We practice maximalist medicine to avoid missing any problem our clinical judgment tells us may be extremely remote," said Alan C. Woodward, MD, an emergency physician and past president of the Massachusetts Medical Society, to Medscape Medical News. Defensive medicine is rampant because "the threat of being sued is pervasive, and doctors simply don't trust the legal system."
In an invited commentary accompanying the Mt. Sinai study, Sen. Orrin G. Hatch (R-UT) acknowledged that consensus on Capitol Hill about tort reform "has been an elusive commodity" because of division and partisanship. "It is my hope that, as the American people see more evidence that they are paying for redundant and unuseful medical procedures, they will demand in larger numbers that real reforms be enacted to address this problem," Sen. Hatch writes. "That is what makes studies like the one by Bishop, et al., so important."
Arch Intern Med. 2010:170:1081-1084.
11. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction
Yeh RW, et al. N Engl J Med. 2010;362:2155-2165.
Background: Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction.
Methods: We identified patients 30 years of age or older in a large, diverse, community-based population who were hospitalized for incident myocardial infarction between 1999 and 2008. Age- and sex-adjusted incidence rates were calculated for myocardial infarction overall and separately for ST-segment elevation and non–ST-segment elevation myocardial infarction. Patient characteristics, outpatient medications, and cardiac biomarker levels during hospitalization were identified from health plan databases, and 30-day mortality was ascertained from administrative databases, state death data, and Social Security Administration files.
Results: We identified 46,086 hospitalizations for myocardial infarctions during 18,691,131 person-years of follow-up from 1999 to 2008. The age- and sex-adjusted incidence of myocardial infarction increased from 274 cases per 100,000 person-years in 1999 to 287 cases per 100,000 person-years in 2000, and it decreased each year thereafter, to 208 cases per 100,000 person-years in 2008, representing a 24% relative decrease over the study period. The age- and sex-adjusted incidence of ST-segment elevation myocardial infarction decreased throughout the study period (from 133 cases per 100,000 person-years in 1999 to 50 cases per 100,000 person-years in 2008, P less than 0.001 for linear trend). Thirty-day mortality was significantly lower in 2008 than in 1999 (adjusted odds ratio, 0.76; 95% confidence interval, 0.65 to 0.89).
Conclusions: Within a large community-based population, the incidence of myocardial infarction decreased significantly after 2000, and the incidence of ST-segment elevation myocardial infarction decreased markedly after 1999. Reductions in short-term case fatality rates for myocardial infarction appear to be driven, in part, by a decrease in the incidence of ST-segment elevation myocardial infarction and a lower rate of death after non–ST-segment elevation myocardial infarction.
12. Images in Emergency Medicine
Rattlesnake Envenomation
http://content.nejm.org/cgi/content/full/362/23/2212
Cutis Marmorata in Decompression Sickness
http://content.nejm.org/cgi/content/full/362/23/e67
Visible Peristalsis
http://content.nejm.org/cgi/content/full/362/24/e68
Radiologic Signs of Pneumoperitoneum
http://content.nejm.org/cgi/content/full/362/25/2410
Benign Paroxysmal Positional Vertigo
http://content.nejm.org/cgi/content/full/362/25/e70
Elderly Woman with Rectal Bleeding
http://www.annemergmed.com/article/S0196-0644(09)01282-7/fulltext
Woman with Leg Rash
http://www.annemergmed.com/article/S0196-0644(09)01448-6/fulltext
13. Predictors of important neurological causes of dizziness among patients presenting to the ED
Cheung C S K, et al. Emerg Med J 2010;27:517-521.
Objectives: Dizziness is a common presenting complaint in the emergency department (ED). This prospective study describes the incidence, causes and outcome of ED patients presenting with dizziness and tries to identify predictors of central neurological causes of dizziness.
Methods: Single-centre prospective observational study in a university teaching hospital ED in Hong Kong. All ED patients (≥18 years old) presenting with dizziness were recruited for 1 month. Symptoms, previous health, physical findings, diagnosis and disposition were recorded. The outcome at 3 months was evaluated using hospital records and telephone interviews. Follow-up was also performed at 55 months using computerised hospital records to identify patients with subsequent stroke and those who had died.
Results: 413 adults (65% female, mean 57 years) were recruited. The incidence of dizziness was 3.6% (413/11 319). Nausea and/or vomiting (46%) and headache (20%) were the commonest associated findings. Hypertension (33%) was the commonest previous illness. Central neurological causes of dizziness were found in 6% (23/413) of patients. Age 65 years or greater (OR=6.13, 95% CI 1.97 to 19.09), ataxia symptoms (OR=11.39, 95% CI 2.404 to 53.95), focal neurological symptoms (OR=11.78, 95% CI 1.61 to 86.29), and history of previous stroke (OR=3.89, 95% CI 1.12 to 13.46) and diabetes mellitus (OR=3.57, 95% CI 1.04 to 12.28) predicted central causes of dizziness.
Conclusions: Most dizzy patients had benign causes. Several clinical factors favoured a diagnosis of central neurological causes of dizziness.
14. Steroid Dosage and Route in Patients Admitted for Chronic Obstructive Pulmonary Disease
Oral low-dose use was associated with less treatment failure than was high-dose parenteral use.
Patients admitted for chronic obstructive pulmonary disease (COPD) usually receive systemic steroids, which have been associated with better outcomes in several prior randomized trials, but the best dose is still in question. Several major clinical practice guidelines recommend low-dose oral steroids.
In a retrospective cohort study, based on data from 414 U.S. hospitals, Massachusetts investigators compared outcomes in nearly 80,000 patients admitted for COPD to non–intensive care unit settings. About 74,000 received parenteral steroids (equivalent to a median dose of 600 mg of prednisone total for the first 2 days), and the rest received oral prednisone (median, 60 mg for the first 2 days). Treatment failure — defined as need for mechanical ventilation after the first 2 days, death, or readmission for COPD within 30 days — occurred in 11% of all patients.
In analyses adjusted for about 50 clinical and demographic variables, as well as propensity scores, treatment failure was 16% lower in patients who received oral low-dose steroids than in those who received parenteral steroids; length of stay and cost were about 10% lower in the low-dose group.
Comment: Although this study was retrospective, its sophisticated analyses convinced editorialists that the results should influence clinical practice and that a randomized controlled trial would be prohibitive in size and cost and is unnecessary. A worrisome secondary finding is that the vast majority of COPD patients received high-dose parenteral steroids, despite the contrary recommendations of major national and international guidelines — including those of the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
— Thomas L. Schwenk, MD. Published in Journal Watch General Medicine June 24, 2010.
Citation: Lindenauer PK et al. JAMA 2010;303:2359.
15. Are 2 smaller intravenous catheters as good as 1 larger intravenous catheter?
Li SF, et al. Amer J Emerg Med. 2010;28:724-727.
Objective: Using Poiseuille's law and standardized gauge sizes, an 18-gauge (g) intravenous catheter (IV) should be 2.5 times faster than a 20-g IV, but this is not borne out by observation, in vitro testing, and manufacturer's data. Our objective was to determine if the infusion rate of a single 18-g IV was equivalent to the infusion rate of two 20-g IVs.
Methods: This was a prospective study in healthy adult volunteers. Subjects simultaneously received 500 mL of normal saline via an 18-g IV in one arm and 500 mL of normal saline via two 20-g IVs in the other arm. We measured the rates of fluid administration. Paired Student's t test was used for comparison of the 2 arms of the study. We estimated that 18 trials were needed in sample size analysis.
Results: Eighteen trials were completed. The mean infusion rate for a single 18-g 500-mL IV administration was 35.6 mL/min (95% confidence interval [CI], 30.3-40.8), with manufacturer's rating being 105 mL/min. The mean infusion rate for two 20-g IVs was 41.3 mL/min (95% CI, 36.1-46.4), with manufacturer's rating being 120 mL/min. The rate of infusion via two 20-g IVs were statistically significantly faster than the single 18-g IV, with a mean difference in flow rate of 5.7 mL/min (95% CI, 1.3-10; P = .026).
Conclusion; In healthy volunteers, administration of intravenous fluids through two 20-g IVs is faster than a single 18-g IV, although both approaches are markedly slower than the manufacturer's estimates.
16. Are routine repeat chest x-rays before leaving the trauma room useful?
Lemmers M, et al. Emerg Med J 2010;27:522-525.
Background: Several guidelines advocate multiple chest x-rays during primary resuscitation of trauma patients. Some local hospital protocols include a repeat x-ray before leaving the trauma resuscitation room (TR). The purpose of this study was to determine the value of routine repeat x-rays.
Methods: One-year data of all radiological imaging in the TR were prospectively collected for all patients presenting to the TR of the hospital. The x-rays were counted and assessed and the findings were classified as either ‘new injury detected’, ‘presence of intervention devices’ or ‘deterioration of previously detected injury’.
Results: A total of 674 patients were included. More than 75% had two x-rays. Eight (2.1%) new injuries without clinical relevance were found on the repeat x-ray after an initial normal x-ray. 61 patients (9%) had a repeat x-ray to verify the effect of an intervention or position of devices. In 28 patients (22%) with two abnormal x-rays, newly diagnosed injuries (n=9) or deterioration of known injuries (n=19) were found. In 411 patients (81%) the results of the repeat x-ray had no clinical consequences.
Conclusion: This study indicates that routine repeat chest x-rays can be omitted in trauma patients whose initial chest x-ray is normal.
17. Normal Renal Ultrasound Might Obviate Need for Computed Tomography in Suspected Urolithiasis
Patients with normal renal ultrasound results had a low rate of urologic intervention within 90 days.
Edmonds ML, et al. CJEM 2010;12:201-206.
Objective: Computed tomography (CT) is an imaging modality used to detect renal stones. However, there is concern about the lifetime cumulative radiation exposure attributed to CT. Ultrasonography (US) has been used to diagnose urolithiasis, thereby avoiding radiation exposure. The objective of this study was to determine the ability of US to identify renal colic patients with a low risk of requiring urologic intervention within 90 days of their initial emergency department (ED) visit.
Methods: We completed a retrospective medical record review for all adult patients who underwent ED-ordered renal US for suspected urolithiasis over a 1-year period. Independent, double data extraction was performed for all imaging reports and US results were categorized as “normal,” “suggestive of ureterolithiasis,” “ureteric stone seen” or “disease unrelated to urolithiasis.” Charts were reviewed to determine how many patients underwent subsequent CT and urologic intervention.
Results: Of the 817 renal US procedures ordered for suspected urolithiasis during the study period, the results of 352 (43.2%) were classified as normal, and only 2 (0.6%) of these patients required urologic intervention. The results of 177 (21.7%) renal US procedures were suggestive of ureterolithiasis. Of these, 12 (6.8%) patients required urologic intervention. Of the 241 (29.5%) patients who had a ureteric stone seen on US, 15 (6.2%) required urologic intervention. The rate of urologic intervention was significantly lower in those with normal results on US (p less than 0.001) than in those with abnormal results on US.
Conclusion: A normal result on renal US predicts a low likelihood for urologic intervention within 90 days for adult ED patients with suspected urolithiasis.
18. The Importance of Being Timely (with regard to reperfusion)
In a population-based cohort with ST-segment-elevation myocardial infarction, time to reperfusion had a stronger effect than method of reperfusion on outcomes.
Lambert L, et al. JAMA. 2010;303:2148-55.
CONTEXT: Guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI) and specify a maximum delay of 30 minutes for fibrinolysis and 90 minutes for primary percutaneous coronary intervention (PPCI). However, randomized trials and selective registries are limited in their ability to assess the effect of timeliness of reperfusion on outcomes in real-world STEMI patients.
OBJECTIVES: To obtain a complete interregional portrait of contemporary STEMI care and to investigate timeliness of reperfusion and outcomes.
DESIGN, SETTING, AND PATIENTS: Systematic evaluation of STEMI care for 6 months during 2006-2007 in 80 hospitals that treated more than 95% of patients with acute myocardial infarction in the province of Quebec, Canada (population, 7.8 million).
MAIN OUTCOME MEASURES: Death at 30 days and at 1 year and the combined end point of death or hospital readmission for acute myocardial infarction or congestive heart failure at 1 year by linkage to Quebec's medicoadministrative databases.
RESULTS: Of 1832 patients treated with reperfusion, 392 (21.4%) received fibrinolysis and 1440 (78.6%) received PPCI. Fibrinolysis was untimely (beyond 30 minutes) in 54% and PPCI was untimely (beyond 90 minutes) in 68%. Death or readmission for acute myocardial infarction or heart failure at 1 year occurred in 13.5% of fibrinolysis patients and 13.6% of PPCI patients. When the 2 treatment groups were combined, patients treated outside of recommended delays had an adjusted higher risk of death at 30 days (6.6% vs 3.3%; odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21-3.93) and a statistically nonsignificant increase in risk of death at 1 year (9.3% vs 5.2%; OR, 1.61; 95% CI, 1.00-2.66) compared with patients who received timely treatment. Patients treated outside of recommended delays also had an adjusted higher risk for the combined outcome of death or hospital readmission for congestive heart failure or acute myocardial infarction at 1 year (15.0% vs 9.2%; OR, 1.57; 95% CI, 1.08-2.30). At the regional level, after adjustment, each 10% increase in patients treated within the recommended time was associated with a decrease in the region-level odds of overall 30-day mortality (OR, 0.80; 95% CI, 0.65-0.98).
CONCLUSION: Among patients in Quebec with STEMI, reperfusion delivered outside guideline-recommend delays was associated with significantly increased 30-day mortality, a statistically nonsignificant increase in 1-year mortality, and significantly increased risk of the composite of mortality or readmission for acute myocardial infarction or heart failure at 1 year.
19. Genomic Medicine — An Updated Primer
Feero WG, et al. N Engl J Med. 2010;362:2001-2011.
Remarkable advances have been made in understanding the human genome's contribution to health and disease since the first Genomic Medicine series was launched in the Journal in 2002… Completion of the Human Genome Project in 2003 was a major driver for the current period of biomedical discovery, and the pace continues to accelerate. This project spurred the development of innovations with extraordinary benefits. Initially, clinically useful discoveries derived from the Human Genome Project yielded improvements in "genetic medicine" — that is, the use of knowledge about single genes to improve the diagnosis and treatment of single-gene disorders. However, our increased understanding of the interactions between the entire genome and nongenomic factors that result in health and disease is paving the way for an era of "genomic medicine," in which new diagnostic and therapeutic approaches to common multifactorial conditions are emerging.
As a result of genomic discoveries, increasing numbers of clinical guidelines now suggest incorporating genomic tests or therapeutics into routine care. In some cases, the rapidity of translation has sparked debate regarding the level of evidence of clinical benefit needed to introduce new, and potentially costly, medical technologies. Although the effect of genomic discovery on the day-to-day practice of medicine has not been well quantified, it probably remains small in primary care and nonacademic settings as compared with, for example, oncology practice in an academic medical center. Regardless of where medicine is practiced, genomics is inexorably changing our understanding of the biology of nearly all medical conditions….
Given the diversity of the human species, there is no "normal" human genome sequence. We are all mutants. [Editor's note: My limited experience confirms that.]
Full-text (free): http://content.nejm.org/cgi/content/full/362/21/2001
20. Immediate β-Blockade in Patients with Myocardial Infarctions: Is There Evidence of Benefit?
Sinert R, et al. Ann Emerg Med. 2010; in press
Study Objective
The American Heart Association recommends the initiation of β-blockade to all patients with an ST-segment elevation myocardial infarction (STEMI) without contraindications to β-blocking agents. The present study seeks to systematically review the medical literature to determine the efficacy of treating STEMI patients with a β-blocker within the first 24 hours.
Methods
We searched databases for articles through MEDLINE with the PubMed interface and from 1966 through May 2009 and EMBASE from 1980 to August 2009 with the Ovid Technologies interface, using a search strategy derived from the following PICO (Patient-Intervention-Comparator-Outcome) clinical question: In patients presenting with STEMI (P), does immediate treatment with β-blockers (I) followed by standardized care beginning on day 2 or 3 compared with placebo or no treatment followed by standardized care on day 2 or 3 (C) reduce the risk of death, reinfarction, or cardiogenic shock (O)? The methodological quality of the studies was assessed.
Results
From more than 2,000 references identified in the search, only a single randomized trial met the inclusion criteria. There were no statistically significant differences in mortality; the relative risk for the combined endpoint (mortality and reinfarction) was 0.67 (95% confidence interval 0.44 to 1.03) at 6 days and 0.74 (95% confidence interval 0.53 to 1.06) at 6 weeks. Outcomes for cardiogenic shock were not reported.
Conclusion
Evidence from a single randomized trial failed to demonstrate a reduction in mortality or reinfarction with administration of β-blocker within the first 24 hours after STEMI.
21. U.S. Scores Dead Last Again in Healthcare Study
By Maggie Fox. WASHINGTON (Reuters) Jun 23 - Americans spend twice as much as residents of other developed countries on healthcare, but get lower quality, less efficiency and have the least equitable system, according to a report released on Wednesday.
The United States ranked last when compared to six other countries -- Britain, Canada, Germany, Netherlands, Australia and New Zealand, the Commonwealth Fund report found.
"As an American it just bothers me that with all of our know-how, all of our wealth, that we are not assuring that people who need healthcare can get it," Commonwealth Fund president Karen Davis told reporters in a telephone briefing.
Previous reports by the nonprofit Fund, which conducts research into healthcare performance and which promotes changes in the U.S. system, have been heavily used by policymakers and politicians pressing for healthcare reform.
Davis said she hoped health reform legislation passed in March would lead to improvements.
The current report uses data from nationally representative patient and physician surveys in seven countries in 2007, 2008, and 2009.
In 2007, health spending was $7,290 per person in the United States, more than double that of any other country in the survey.
Australians spent $3,357, Canadians $3,895, Germans $3,588, the Netherlands $3,837 and Britons spent $2,992 per capita on health in 2007. New Zealand spent the least at $2,454.
And yet Americans get less for their money, said the Commonwealth Fund's Cathy Schoen.
"We rank last on safety and do poorly on several dimensions of quality," Schoen told reporters. "We do particularly poorly on going without care because of cost. And we also do surprisingly poorly on access to primary care and after-hours care."
The report looks at five measures of healthcare -- quality, efficiency, access to care, equity and the ability to lead long, healthy, productive lives.
"On measures of quality the United States ranked 6th out of seven countries," the group said in a statement.
U.S. patients with chronic conditions were the most likely to say they got the wrong drug or had to wait to learn of abnormal test results.
Overall Britain, whose nationalized healthcare system was widely derided by opponents of U.S. healthcare reform, ranks second, the Commonwealth team found. The Netherlands ranked first.
"The findings demonstrate the need to quickly implement provisions in the new health reform law and stimulus legislation that focus on strengthening primary care, realigning incentives to reward higher quality and greater value, investing in preventive care, and expanding the use of health information technology," the report reads.
Critics of reports that show Europeans or Australians are healthier than Americans point to the U.S. lifestyle as a bigger factor than healthcare. Americans have higher rates of obesity than other developed countries, for instance.
"On the other hand, the other countries have higher rates of smoking," Davis countered. And Germany, for instance, has a much older population more prone to chronic disease.
Every other system covers all its citizens, the report noted and said the U.S. system, which leaves 46 million Americans or 15% of the population without health insurance, is the most unfair.
"The lower the performance score for equity, the lower the performance on other measures. This suggests that, when a country fails to meet the needs of the most vulnerable, it also fails to meet the needs of the average citizen," the report reads.
Cf: http://www.commonwealthfund.org/Content/Publications/Fund-Reports/2010/Jun/Mirror-Mirror-Update.aspx
Subscribe to:
Posts (Atom)